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Abstract of the Dissertation
Mass Spectrometry-Based Strategies for Biomolecular Structure Analysis: Steroid Metabolites
Structures and Protein-Protein Interactions
by
Yuetian Yan
Doctor of Philosophy in Chemistry
Washington University in St. Louis, 2015
Professor Michael L. Gross, Chair
Professor Timothy E. Holy, Co-Chair
Mass spectrometry is an important method for studying the structure of both small molecules
and large biomolecules (e.g., proteins). The majority of the applications prior to 1970 were
focused on small molecules, owing to the limited ionization methods which posed difficulties in
producing gas-phase ions for large biomolecules then. Beginning in the 1980’s, with the
introduction of new ionization methods (ESI and MALDI), the applications have gradually
switched to biological science measuring large bioorganic molecules. Today, with the
developing interest in metabolomics and proteomics, and ongoing improvement in MS-based
techniques, mass spectrometry is extensively applied in the study of both small and large
molecules.
The research presented in this thesis falls into two main parts, which focus on the application of
MS in (1) structural analysis of steroid metabolites and (2) characterization of protein-protein
interactions. In the first part, combinations of different MS methods are adopted and used to
solve the structures of unknown steroid metabolites, which are the pheromones responsible for
mouse communication in mouse urine. This part includes three chapters, the first two of which
discuss the method development of using MS to study the structure of steroid metabolites; and
the third chapter presents the application of the MS methods in solving a newly discovered
steroid pheromone, which is determined as a sex-specific hormone. In the second part, two MSxiii

based strategies, namely, hydrogen-deuterium exchange (HDX) and fast photochemical
oxidation of proteins (FPOP), are applied in two studies of protein-protein interactions, including:
(1) dimerization of SecA, which is a motor protein in bacteria translocation pathway; and (2)
interface mapping of EGFR binding to Adnectin1. In the first chapter in Part 2, we used HDX
MS to characterize the dimer interface of SecA, and, meanwhile, detected a conformational
change from open to closed forms at the pre-protein binding domain upon dimerization. This
conformational change provided leads for the active form of SecA. In the second chapter in Part
2, we applied FPOP, which is modified to suit therapeutic protein formulation conditions, to map
the epitope of Adnectin1-EGFR interaction at amino acid residue level. The epitope identified
agrees with that from both HDX study and crystallography results, presenting more evidence of
the capability of FPOP in epitope mapping.
These five studies on characterization of steroid metabolites and protein-protein interactions
show the successful application of mass spectrometry in the structural study of both small
molecules and large proteins. Furthermore, there’s a great potential for study of more complex
systems.
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Chapter 1
Introduction: Mass Spectrometry Assists Structural
Analysis of Steroid Metabolites Important in Mouse
Communication

1

1.1 Abstract
Among mice, social behavior, such as sex, social status, and identity is organized via
pheromones and other odor cues in chemical signaling. The molecular identity of these signals,
however, remains largely unknown. Recently, a group of steroid conjugates in mouse urine was
found to serve as important ligands for the pheromone-sensing neurons. Although two of those
steroid metabolites were structurally analyzed with NMR and mass spectrometry, many more
remains structurally unresolved. These steroid metabolites, which occur in trace amounts in
mouse urine and elsewhere and, therefore, are difficult for NMR study, are challenging to
characterize. In the first part of this thesis, we explored the application of a combination of MS
tools for determining structure of steroid metabolites. In the area of steroid conjugates analysis,
mass spectrometry dates back to the 1950s, first using electron ionization (EI). With further
development of mass spectrometry, other suitable methods for structure characterization became
available for the study of steroid conjugates, including different types of tandem mass
spectrometry. In this chapter, we give an introduction to the techniques and instrumentation in
mass spectrometry that can be applied in structural study of steroid metabolites; we also review
the history of steroid conjugates study by mass spectrometry.

2

1.2 Social Communication of the Mouse
Animals are social. They use their sense of smell to identify and learn the status of other
animals. Natural cues such as urine-containing metabolites inform about reproductive status,
social dominance, and levels of stress(1). By investigating various bodily fluids, such as urine, an
animal can discriminate between individuals and “communicate”.
For many mammals, olfactory sensations derive from at least two anatomically and
molecularly distinct neural pathways, the main and accessory olfactory systems. The main
olfactory system is composed of main olfactory epithelium (MOE) that contains olfactory
sensory neurons (OSNs). Chemical cues are detected in the MOE after they bind to G proteincoupled receptors on the cilia of OSNs. For a long time, the main olfactory system was believed
to utilize only volatile chemical cues and trigger innate physiological or behavior responses(2-4).
Recently, evidence appeared showing that murine OSNs can also respond to small, nonvolatile
major histocompatibility complex (MHC) peptide ligands that lead to changes in behavior(5).
Similarly, the accessory olfactory system is composed of the vomeronasal organ (VNO)
epithelium, which contains vomeronasal sensory neurons (VSNs). Odorants that are dissolved in
nasal mucous gain access to the VNO via an active pumping mechanism(6) and then bind to the G
protein-coupled receptors located on VSNs. Although it was presumed that the VNO
preferentially responds to large-molecular-weight, nonvolatile molecules, it has also been shown
to respond to volatile chemosensory stimuli in vitro(7, 8).
Unlike the main olfactory system, the accessory olfactory system plays a more narrowly
specialized role for social communication. Previous studies showed that VNO lesions lead to
deficits in reproductive and territorial behaviors in mice(9-13). More than two decades ago,
Wysocki and his colleagues studied the importance of VNO by using a dental burr to enlarge the
3

incisive foramen and then remove the entire VNO (VNX)(14). Many following-up studies(9) have
been published from the same group, reporting VNX impaired abilities including ultrasonic
vocalizations in males, hormone surges in response to cues from females, male-mouse courtship
and sexual behavior, territorial marking and inter-male aggression, and maternal behaviors in
females. More recently, several other groups genetically mutated mice to form a homozygous
deficiency in Trp2, a cation channel expressed in the VNO. These Trp2 mutants reveal a striking
reduction in the electrophysiological response to pheromones in the VNO, and, therefore afford
the opportunity to examine the role of VNO in the generation of innate social behaviors in mice.
The studies(10,

11, 13)

showed that Trp2 mutant males and nursing females fail to display

aggression on intruder males, Trp3 mutant female showed reduction in lactating behavior, and
trp2 mutant male also lost sex discrimination and initiated sexual behaviors toward both males
and females. All these findings suggest that VNO-mediated pheromone input regulates important
sexual and social behaviors in mice.

1.3 Vomeronasal Agonists Carry Pheromone Information
Pheromones are chemical cues that are released by animals to regulate their social
interactions within the same species. Although there are many known ligands found for main
olfactory sensory neurons, only a small number of agonists carrying pheromone information for
VSNs have been identified thus far, in contrast to the many chemosensory receptors found in the
rodent nose. Behaviorally, the most well characterized source of VSN ligand is urine, because
mice employ urine investigation as a tool to discriminate between individuals and urine also
comes available in relatively large quantities. Among the known chemicals carrying pheromonal
information, several volatile molecules(8,

15)

were identified to be VSN agonists. In addition,

nonvolatile major histocompatibility complex (MHC) class I peptides(16) and major urinary
4

proteins (MUPs)(17) have been reported to activate selectively VSNs. Altogether, these identified
vomeronasal agonists are far less numerous than the amount of chemosensory receptors found in
the rodent nose (more than 1300(18)). Also, these molecules at saturating concentrations were
reported together to stimulate fewer than 15% of the neurons, whereas hundred-fold diluted urine
stimulated 30-40% of the neural population(7). Both facts indicate that there are more compounds
that are responsible for most of the activity in mouse urine unidentified.
In an effort to search for the unidentified source responsible for most of the activity in
dilute urine, Nodari et al.(19) adopted a de novo screen of active constituents of mice urine by
presenting chromatographic fractions of urine to VSNs and recording their neuronal firing
responses. As a result, a large family of compounds that collectively accounts for much of the
activity in female mouse urine was identified, most of which contain a sulfate group and two are
structurally characterized as sulfated steroids(20) by using nuclear magnetic resonance (NMR)
and mass spectrometry (MS). Indeed, several lines of evidence suggest that urine contains other
active, but unknown, sulfated steroids. In fact, the urine from female mice of the BALB/c strain,
contains sulfated compounds estimated to produce 80% of the total activation of these sensory
neurons(19).
Unfortunately, like many metabolites, many of the unknown cues in natural stimuli are
present in very low abundance, restricting the possibility of using NMR analysis for structure
identification. Therefore, more sensitive methods are needed, and the first part of this thesis
describes the exploration of various combinations of MS methods to determine steroidmetabolite structure, and demonstrates its successful application to solve one unknown and
putative female sex pheromone.

5

1.4 Mass Spectrometry
Mass spectrometry (MS) is a microanalytical technique that can be used to determine the
elemental and isotopic signature of an analyte and provide some aspects of its molecular
structure. The simplest mass spectrometer is composed of an ion source, a mass analyzer, and a
detector. In a typical MS procedure, a sample, which might be solid, liquid, or gas, is ionized to
form ions in gas phase before they are separated according to their mass-to-charge ratios (m/z).
The majority of applications prior to 1970 were analysis of small molecules, because only
analytes having significant vapor pressure could produce gas-phase ions by the only commonly
available ionization techniques at that time, electron ionization (EI) and chemical ionization (CI).
After 1970, the capabilities of MS were expanded by the development of desorption/ionization
(D/I) techniques, which enables generating gas-phase ions directly from a condensed phase.
However, it was not until the late 1980’s, when John Fenn invented electrospray ionization
(ESI)(21), Fanz Hillenkamp and Michael Karas developed matrix-assisted laser desorption
ionization (MALDI)(22), that MS become vastly applied in biological science for measuring
bioorganic molecules, including peptides, proteins, carbohydrates, and DNA or RNA fragments.
Today, EI and CI continue to play very important roles when combined with gas
chromatography (GC/MS), whereas ESI and MALDI are mainly responsible for the dominant
role of MS in the biological sciences. GC/MS now is a mature technique in analysis of small
molecules, supported by several large online databases. ESI and MALDI are even more routinely
used in both small and large molecule analysis owing to easy sample handling and the
requirements for only small sample quantity.
Besides the availability of various ionization techniques, the success of MS in science
today is also attributable to combining different mass analyzers to afford hybrid mass
6

spectrometers that provide high-mass resolving power measurements. In conducting this thesis
research, three hybrid mass spectrometers were mainly used; they all involve ESI (including
nanospray) combined with linear ion trap/Orbitrap, GC-quadrupole/time-of-flight (TOF), and
MALDI-TOF/TOF. These are described in the following sections.

1.4.1 Quadrupole/Time-of-Flight Mass Spectrometers
1.4.1.1 Quadrupole Mass Analyzer
As indicated by its name, a quadrupole mass analyzer (sometimes called quadrupole mass filter
or QMF) is composed of four parallel rods that ideally form a hyperbolic cross section. Each
opposing rod pair is connected together and held at the same polarity. A radio frequency (RF)
and direct current (DC) voltage are applied between one pair of rods and the other. Extracted
ions from an ion source travel down the quadrupole between the rods along the longitudinal axis
toward the detector. Only ions of a certain m/z will reach the detector for a given U (magnitude
of the DC potential) and V (magnitude of the RF signal), given a constant AC frequency, and
other ions will collide with the rods owing to unstable trajectories. This is mathematically
modeled with the use of the Mathieu differential equation(23). And this property of the QMF
enables a quadrupole either to function as a mass selector in which only ions with specific m/z
can be transmitted, or to scan a mass spectrum by increasing or decreasing U and V at a fixed
ratio from a pre-established minimum to a maximum value.
Selective transmission of ions over a narrow m/z by the quadrupole is most often used in tandem
MS (MS/MS) analysis mode to select a precursor ion for study. One example instrument
designed for such analysis is a triple quadrupole mass spectrometer, which is composed of a
linear set of three quadrupoles in series. The first (Q1) and third (Q3) quadrupoles act as mass
filters, and the second (Q2) quadrupole is operated in the RF-only mode (transmits ions of all m/z
7

Figure 1- 1. A schematic of a triple quadrupole mass spectrometer (QQQ-MS). Q1 and Q3
represent two mass filters for precursor and fragment ion selection while Q2 (collision cell)
creates

fragment

ions

via

collision-induced

dissociation

(CID).

Taken

from

http://www.particlesciences.com/news/technical-briefs/2009/mass-spectrometrybioanalysis.html.
values) to serve as a collision cell(24,

25)

. Q1 is used for selection of the precursor ions and

transmitting them to Q2, where collisions of the precursor ions with an appropriate concentration
of collision gas (Ar, He, or N2) occurs, and product ions are formed. These product ions are
passed to Q3 where they may be fully scanned to give a mass spectrum or transmitted over a
narrow range to achieve “selected reaction monitoring” whereby duty cycle and sensitivity are
increased (Figure 1-1).
In modern mass spectrometry, quadrupoles are very often used in hybrid mass spectrometers.
The tandem quadrupole-TOF (QTOF) mass spectrometer uses a time-of-flight device as the
second mass analyzer and has the advantage of improved mass accuracy to the nearest 0.1
millimass unit vs. using a quadrupole for the second mass analyzer.
1.4.1.2 Time-of-flight Mass Spectrometry
Time-of-flight (TOF) mass spectrometry is a method that separate and detect ions of different
m/z in a field-free drift path after the application of a constant acceleration voltage (U) for all
ions. After the initial acceleration with a high electrical potential, we can equate two types of
energies as:
E = qU = ½ mv2 = Ek

Eq. 1
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The velocity (v) of the ion in the flight tube, therefore, can be obtained.
2qU

v

Eq. 2

m

Because the field-free drift tube is at a fixed length (l), the time that an ion takes to reach the
detector depends on its velocity, and, therefore, its mass-to-charge ratio. By measuring this time
and using the known experimental parameters, the m/z of the ion can be determined from the
following equation deduced from Eq. 2:
m
z

=

2U
v2

2U
l/t 2

Eq. 3

If the TOF is coupled with a reflectron, the kinetic energy dispersion in the direction of ion flight
can be corrected, and as a result the mass resolving power is significantly improved. A modern
Q-TOF instrument can have mass resolving
power of 60,000 over a wide mass range.

1.4.2 Linear Ion Trap/Orbitrap
Mass Spectrometers
1.4.2.1 Linear Ion Trap
The linear ion trap, or linear quadrupole ion
trap (LIT or LTQ, Figure 1-2a), uses a set
of quadrupole rods to confine ions radially
(by employing an RF potential) and a static
electrical potential applied to end electrodes
to confine the ions axially(26). A common

Figure 1- 2. a. The linear ion trap. b. The
chamber of the 3D quadruple trap. Taken from
http://employees.csbsju.edu/hjakubowski/classe

instrument from Thermo Fisher, the LTQ,

s/ch331/protstructure/olcompseqconform.html.
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makes use of a transmission quadrupole that can be used as a selective mass filter, but unlike a
transmission quadrupole, it can also function as an actual trap by creating a longitudinal potential
well for the ions(27). The LTQ has the advantages of larger ion storage capacity than the 3D
quadrupole trap (Figure 1-2b). These properties allow LTQ to exceed the triple quadrupole in
MS/MS analysis to achieve a better signal-to-noise ratio by accumulating ions in MS2 before
acquiring a mass spectrum of the product ions. Furthermore, this trapping property of the LTQ
makes MS3 or further possible without further complex construction, but this is also true of 3D
traps. This advantage in tandem mass spectrometry is especially advantageous in the structural
analysis of small molecules, which will be the focus of the first part of my thesis.
1.4.2.2 Orbitrap Mass Spectrometry
The orbitrap, which is a modification based on the Kingdon trap(28), is a type of Fourier
transform mass spectrometer. The orbitrap is
composed

of

two

coaxial

axisymmetric

electrodes, the inner spindle-shaped electrode and
an outer barrel-shaped surface (Figure 1-3). A
constant electric potential is imposed between the
two electrodes, and, therefore, ions can be
trapped in the space between them by balancing
the electrostatic attraction to the inner electrode
Figure 1- 3. Cutaway view of the
by the centrifugal force of the spinning ions.

Orbitrap mass analyzer. Ions are injected

Furthermore, the opposing surfaces of the

into the Orbitrap at the point indicated by

axisymmetric coaxial electrodes are nonparallel,

the red arrow. Taken from Perry et al.
2008. Mass Spectrometry Reviews. Page

leading to varying electric field between the two
10

664.

surfaces along the z-axis, reaching a minimum at the center of the orbitrap. The electric-field
vectors are nonparallel, with decreasing projection of the electric field onto the z-axis toward the
center of the trap, which is the force driving the ions toward the center of the trap along the zaxis. Therefore, besides cycling around the inner electrode, the ions also have a natural tendency
to oscillate axially (along the z-axis) in the orbitrap. Owing to properties of quadro-logarithmic
potential(29), this axial motion is harmonic, with its angular frequency dependent on its m/z:
q

ωz= k
m

Eq. 4

where k is the force constant/ field curvature. This oscillation feature allows the orbitrap to
function as a mass spectrometer, and the ion signal is detected as a time-domain signal by using
image current detection as sensed by the halves of the barrel electrode; the image current is then
Fourier transformed to frequency-based signal. Image current detection is also at the heart of FT
ICR mass spectrometers, and was first utilized with that instrumentation over 40 years ago.
The orbitrap analyzer can be interfaced to a linear ion trap, which together provide very high
resolving power (100,000 at m/z 400) and efficient MS/MS capability. Therefore, much of the
research reported here in this thesis (both the first and second parts) was conducted with LTQOrbitrap interfaced to capillary HPLC.

1.5 Gas-Phase Fragmentation
Mass Spectrometry studies its subjects in their ionic forms in the gas phase. In the ion source, an
atom or molecule is converted into an ion in the gas phase by adding or removing charged
particles, such as electrons or protons. The neutral substance is either admitted to the gas phase
prior to or accompanying ionization. In Electron ionization (EI) and chemical ionization (CI), the
excess energy introduced upon ionization almost always leads to fragmentation of the molecule.
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This fragmentation pattern can be viewed as a “chemical fingerprint” and is useful in the study of
molecular structure. In other soft ionization processes, such as electrospray ionization (ESI), very
often only molecular ions are formed. In such situations, the molecular ions can be purposefully
fragmented by collision-induced-dissociation with collision gas in a collision cell, which is built
before the mass analyzer, to help understand the structure. Such gas-phase fragmentation remains
very important and widely used in modern mass spectrometry for study of both small molecules
and large biomolecules.

1.5.1 Electron Ionization
Electron ionization (EI) is a widely used ionization method in mass spectrometry that uses
energetic electrons to interact with gas-phase molecules to produce ions. In an EI ion source,
electrons are produced by electrically heating a thin metal filament to a temperature at which
thermionic emission occurs. The electrons are then accelerated to 70 eV, concentrated into a
beam, and directed toward the sample gas which is introduced in the ion source perpendicular to
the beam. The electric field around the sample neutral molecules undergoes large fluctuation
because of the close passage of highly energetic electrons, and, therefore, causes the sample
molecules to ionize and fragment. The following gas phase reaction describes the ionization
process.
M + e-

M+• + 2e-

Eq. 5

The ionization process is often followed by predictable fragmentation. The fragmentation pattern
of the molecular ion can be used to deduce the structural features of the analyte. Knowledge in
organic chemistry, such as electron-triggered cleavages and rearrangements and chemical bond
stability, are used to suggest or to rationalize the fragmentation pathways. Many analytes have a
unique “chemical fingerprint”, therefore EI has been widely used in structure studies of natural
12

products and, more recently, in metabolism. Furthermore, there are commercially available
libraries containing hundreds of thousands of reference EI mass spectra which can be used to
facilitate identification of unknown compounds.
Today, EI is mostly used in GC-MS instruments because it is most easily adapted to gas-phase
sample ionization. In the study of small molecule structure characterization, we used one such
instrument to show the application of EI in the structural study of unknown steroid metabolites
and its value in structure elucidation.

1.5.2 Tandem Mass Spectrometry
Desorption/ionization (D/I) has greatly advanced mass spectrometry in several application areas,
the most important of which is the identification of large bioorganic molecules. Now
electrospray ionization (ESI) and matrix-assisted laser desorption/ionization coupled mass
spectrometers are the two most popular instruments in a mass spectrometry lab. These ionization
methods produce protonated molecules ([M + H]+) in the positive-ion mode and deprotonated
molecules ([M - H]-) in the negative-ion mode

of the instrument, or in some cases

cationized/decationized molecules. Most of the ions formed by such soft ionization techniques
are even-electron species and, therefore, do not undergo fragmentation when formed by soft
ionization. Thus, although they are useful in providing the molecular mass of the analyte, they
are also disappointing in not providing much, if any, structural information. This problem is
solved by combining tandem mass spectrometry with the soft ionization technique, like ESI or
MALDI.
There are many methods used to fragment ions, and they result in different types of
fragmentation. In the following, we will introduce the two tandem mass spectrometry methods
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that were used in the research presented in this thesis; they are low-energy collision-induced
dissociation and high-energy charge-remote fragmentation.
1.5.2.1 Collision-induced Dissociation
Collision-induced dissociation (CID) is most often what is being used in a tandem mass
spectrometry experiment. It is achieved by introducing neutral target molecules or atoms into the
collision cell and inducing collisions with the accelerated analyte ions in the gas phase. As a
result, energy is added to the ions as internal energy that leads to subsequent bond breakage and
fragmentation of the ions.
CID of Peptides and Proteins
The ability to generate fragment ions in
tandem mass spectrometry (or MS/MS) is very
important for the identification of an analyte
with high confidence. MS/MS is now widely
used in protein mass spectrometry, and is

Figure 1- 4. The fragmentation sites of

almost indispensable for identification of

peptide during gas-phase fragmentation.

peptides and proteins. Peptide ions that are fragmented with CID produce a series of product
ions, namely b ions if the charge is retained on the N-terminus and y ions if the charge is retained
on the C-terminus (Figure 1-4). Other fragment ions, indicated by a, c, x, or z in Figure 1-4, can
also be formed in gas-phase with other fragmentation methods, but these methods were not
utilized in this thesis. This application of CID MS/MS in peptide identification is important in
the second part of this thesis.
CID of Small Molecules
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The application of CID for small molecules, especially in structure identification, however,
remains limited. This is partly because structural chemists turn to NMR in structure studies in
cases where sample quantity is not limited. More importantly, structural elucidation with CID is
complicated and sometimes incomplete. Although some basic theories and rules of fragmentation
have been proposed, the deduction of fragmentation remains difficult when facing complicated
molecules including steroids. Despite such difficulties in data analysis, CID mass spectrometry is
an important tool in studying complex biological samples including biological fluids. A subject
for our study in this thesis, mouse urine, is a challenging sample from which fractionating and
obtaining sufficient analyte for NMR analysis is most times difficult. In the first part of this
thesis, we focused on MS/MS and MS/MS/MS of steroid sulfates to understand their general
fragmentation patterns, and discovered several fragmentation rules that we applied to the
characterization of one unknown steroid metabolite.
1.5.2.2 Charge-remote Fragmentation
Charge-remote fragmentation (CRF) is a class of gas-phase decompositions that occurs remote
from the charge site(30-32). The two important criteria that enable charge-remote fragmentation are
(1) a charge fixed at one end of the molecule and (2) high-energy collisional activation (> 10,000
eV in the laboratory frame). The ionization method is not a prerequisite for CRFs, although the
mostly frequently used ionization method for generating precursor ions was fast atom
bombardment (FAB). Provided sufficient energy is deposited on a molecule, other
complementary ionization methods can also be utilized to ionize samples prior to CRF.
Although it is generally agreed that CRF proceeds similarly to gas-phase thermal reactions and
the charge is not involved in the fragmentation, the detailed mechanisms and energetic are still
debated. For fatty acids, charge-remote cleavage of C-C bonds can be explained by a 1,4-H2
15

elimination mechanism (Scheme 1-1(33) ). On the other hand, a radical mechanism initialized by a
homolytic C-C bond cleavage may also be operative (Scheme 1-2(34, 35)). Other mechanisms(36, 37)
were also proposed later. However, none of them can explain all the data on CRF.
Charge-remote fragmentation has been proven useful in the structure characterization of longchain or poly-ring molecules(38-42). Early CRF experiments were performed mostly on sector
instruments that are capable of providing high collision energies. However, there has been a
marked decline in the application of high-energy CID with the demise of magnet sector
instruments and the current dominance of ion traps, QTOFs, and hybrid ion-trap FT
spectrometers that employ low-energy CID. Recently, interest resumed in CRF with the
introduction of TOF/TOF instruments that provide high collision energies(43-46). The introduction
of a first TOF and an accelerating voltage before the collision cell in the design of the TOF/TOF
instruments enabled precursor ions to gain a high kinetic energy, which is usually between 1 to
20 kV (e.g., 20 kV accelerating voltage
equals to 20 keV kinetic energy for a
singly charged species). As a result, the
precursor ions have high kinetic energy
and high-energy collision is allowed

Scheme 1- 1. 1,4-H2 elimination mechanism
proposed by Gross and co-workers. X may
correspond to O- or OLi2+.

with neutral gases when entering the
collision cell. As part of the research in
the first part of the thesis, we showed
the application of MALDI TOF/TOF
instrumentation to induce CRF and
Scheme 1- 2. Homolytic bond-fragmentation
mechanism. X may correspond to O- or OLi2+.
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enable structural characterization of steroid metabolites.

1.6 MS-Based Structural Analysis of Steroid Conjugates
Biological MS dates back to the 1950s, when steroid was one of the first class of biomolecules
analyzed by MS(47). In the early studies of steroids, EI was the dominant ionization method and
later was coupled with GC. GC/MS offers very good chromatographic separation of analytes
even those with minor structural differences (e.g., isomers). Meanwhile, EI produces informative
and often characteristic fragmentation, therefore the structural information is forthcoming.
However, for the majority of the steroid analysis, derivatization is required to form volatile
compounds to be analyzed by GC(48). Because the sample injection volume (1-5 µL typically) is
small, intense analyte cleanup and concentration prior to analysis are often required to provide
sufficient intensity of analyte signals for detection. EI spectra are often complicated, and made
even more so with derivatization that leads to more fragments of the derivative itself. Despite the
difficulties, GC/MS is still routinely used in structure analysis, partly due to the availability of a
vast EI online data base for structural identification of analytes.
The introduction of the desorption-ionization techniques of fast atom bombardment(49, 50) and
ESI(51, 52) bypassed the problems of analyte volatility and thermal stability, and allowed direct
coupling with liquid chromatography (LC) for analyte separation. The development of tandem
mass spectrometry (MS/MS)(53, 54) about the same time (1980a) afforded a new approach for
structural characterizations of steroid conjugates with mass spectrometry. This approach used
FAB ionization on magnetic-sector instruments and high collision energies to generate chargeremote fragmentation. The approach was demonstrated effective in resolving structures of bile
salt conjugates and other steroids(40-42, 55). Today, we are using direct-inlet ESI rather than FAB,
and sector instruments have been replaced with ion traps, QTOFs, and hybrid ion-trap FT
17

spectrometers that employ low-energy CID. Over the years, low-energy CID has seen some
application in structure characterization of steroid sulfates(56), but the data interpretation often
stops at accurate mass and functional group fragmentation to deduce known steroid metabolites
in a sample mixture. Recently, high-energy CID(43,

44)

has been resumed with TOF/TOF

instruments, and applied in some areas for structural characterization(45, 46, 57, 58).

1.7 Purpose of this Study
In the first part of the thesis research, we utilized all the different MS approaches mentioned
above for the structure characterization of steroid metabolites in Chapter 2 and Chapter 3. We
then applied this combination of MS methods in Chapter 4 in the study of mouse urine to solve
the structure of an unknown steroid sex pheromone that is important in mouse communication.
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Chapter 2*
Mass Spectrometry Combinations for Structural
Characterization of Sulfated-Steroid Metabolites

*

This chapter is based on recent publication: Yan, Y., Rempel, D. L., Holy, T. E., Gross, M. L..
Mass spectrometry combinations for structural characterization of sulfated-steroid metabolites. J
Am Soc Mass Spectrom, 2014, 25(5), 869-79.
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2.1 Abstract
Steroid conjugates, which often occur as metabolites, are challenging to characterize. One
application is female-mouse urine, where steroid conjugates serve as important ligands for the
pheromone-sensing neurons. Although the two with the highest abundance in mouse urine were
previously characterized with mass spectrometry (MS) and NMR to be sulfated steroids, many
more exist but remain structurally unresolved. Given that their physical and chemical properties
are similar, they are likely to have a sulfated steroid ring structure. Because these compounds
occur in trace amounts in mouse urine and elsewhere, their characterization by NMR will be
difficult. Thus, MS methods become the primary approach for determining structure. In this
chapter, we show that a combination of MS tools is effective for determining the structures of
sulfated steroids. Using 4-pregnene analogs, we explored high-resolving power MS (HR-MS) to
determine chemical formulae; HD exchange MS (HDX-MS) to determine number of active,
exchangeable hydrogens (e.g., OH groups); methoxyamine hydrochloride (MOX) derivatization
MS, or reactive desorption electrospray ionization with hydroxylamine to determine the number
of carbonyl groups; and tandem MS (MSn), high-resolution tandem MS (HRMS/MS), and GCMS to obtain structural details of the steroid ring. From the fragmentation studies, we deduced
three major fragmentation rules for this class of sulfated steroids. We also show that a combined
MS approach is effective for determining structure of steroid metabolites, with important
implications for targeted metabolomics in general and for the study of mouse social
communication in particular.
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2.2 Introduction
Determining the structure of steroid conjugates is a major challenge in metabolomics.

A

particular need is to understand animal communication. Mammals use their sense of smell to
identify and learn the status of other animals. Natural cues such as urine contain metabolites
informative about reproductive status, social dominance, and levels of stress(1). In most cases,
however, the identity of the signaling compounds remains unknown. A recent study(2) used the
responses of olfactory neurons in the mouse vomeronasal organ, specializing in the detection of
“social odors” or “pheromones” produced by other animals, to assay the activity of purified urine
fractions. The structures of two active compounds were determined(3), by using a combination of
mass spectrometry (MS) and nuclear magnetic resonance (NMR), were shown to be sulfated
steroids of the glucocorticoid family. Because steroids are among the main regulators of
mammalian physiology(4), their metabolites are attractive candidates for conveying many aspects
of an animal’s status. Indeed, several lines of evidence suggest that urine contains other active,
but unknown, sulfated steroids. For the urine from female mice of the BALB/c strain, sulfated
compounds account for an estimated 80% of the total activation of these sensory neurons(2).
Unfortunately, like many metabolites, many of the unknown cues in natural stimuli are present in
much lower abundance than the two compounds identified by Hsu et al.(3), and consequently
present a greater challenge for structural analysis. MS is particularly apt for obtaining structural
information from small sample quantities, but we felt that a single MS method would not be
adequate. Thus, the purpose of the research reported in this chapter is to explore the effectives of
various combinations of MS methods to determine steroid-sulfate structure.
For many years, steroidal hormones have been analyzed by gas chromatography-mass
spectrometry (GC-MS) since Sweeley and Horning’s(5) first success in 1960. More recently,
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steroids were also analyzed by using HPLC coupled with tandem mass spectrometry (LCMS/MS)(6-12). GC has the advantages over LC of higher chromatographic resolution, affording
specificity for minor structural differences, as well as a vast EI online database for structural
identification of analytes. GC-MS, however, requires some knowledge of the analytes’ structure,
because GC’s reliance on volatility often necessitates functional-group-specific derivatization. In
contrast, LC-MS/MS requires less initial knowledge of the structure of the sample, as
derivatization is not a requirement for ionization. This eases the handling requirement for the
sample and reduces possible losses of material during sample preparation.
In this chapter, we describe a combination of methods, taking advantage of both GC-MS and
LC-MS/MS, which constitute a MS-based “tool box” for studying structures of sulfated steroids.
Although each tool is not new, we wished to explore whether a combination would offer an
effective approach to steroid identification.

To demonstrate, we focused on a set of six

commercial or custom-synthesized 4-pregnene steroids, a key class of compounds because they
are central in steroid biosynthetic pathways in the mouse(13). The 4-pregnenes sulfates were
chosen because they are structurally similar to previously identified sulfated steroids found in
mouse urine and active for mouse communication. We also anticipate that more unknown
sulfated steroids belonging to this category exist in mouse urine. The combination we selected
include different MS-based approaches including 1) high mass-resolving-power MS (HR-MS) to
determine chemical formula; 2) HD exchange MS (HDX-MS) to determine number of active
hydrogens (e.g., –OH groups); 3) methoxyamine hydrochloride (MOX) derivatization MS, or
online derivatization with hydroxylamine by reactive desorption electrospray ionization, to
determine the number of carbonyl groups; and 4) tandem MS (MSn), high-resolution tandem MS
(HRMS/MS), and 5) GC-MS to probe details of the steroid-ring structure. From the
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fragmentation studies, we can draw some generalized fragmentation rules for sulfated-steroid
CID MS/MS. This combination of MS-based methods provides an opportunity to “footprint”
steroid sulfates metabolites, providing a foundation for sequel studies of mouse social
communication.

2.3 Materials and Methods
2.3.1 Materials
Sulfated steroids, including 4-pregnen-11β, 21-diol-3, 20-dione 21-sulfate (termed SS425,
standing for sulfated steroid 425, the number of which is the molecular mass of [M - H]-), 4pregnen-11β, 17, 21-triol-3, 20-dione 21-sulfate (SS441) and 4- pregnen-17, 21-diol-3, 11, 20trione 21-sulfate (SS439), and steroids, including 5β- pregnan-11β, 21-diol-3, 20-dione, 5αpregnan-3α, 11β, 21-triol-20-oneand 4- pregnen-11β, 20β, 21-triol-3-one were purchased from
Steraloids Inc (Newport, RI), and dissolved in methanol to 5 mM as stock solution. Strata-X 33u
polymeric reversed phase 60 mg/3 m for solid phase extraction (SPE) was purchased from
Phenomenex (Torrance, CA). All other chemicals and reagents were purchased from Sigma
Aldrich (St. Louis, MO).

2.3.2 Sulfation of Steroids
Sulfation methods to synthesize sulfated steroids from steroids were modified from that of
Kornel et al.(14) to suit for micro-synthesis. Acidified pyridine was prepared by adding 0.3 mL
chlorosulfonic acid dropwise to 5 mL dry pyridine while cooling on an ice bath. To sulfate
steroids 5β- pregnan-11β, 21-diol-3, 20-dione, 5α- pregnan-3α, 11β, 21-triol-20-one and 4pregnen-11β, 20β, 21-triol-3-one, 5 µL of 5 mM stock steroid solution was dried by using a
SpeedVac at room temperature, and the residue redissolved in 80 µL pyridine. Acidified pyridine
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(30 µL) was then added, and the mixture was shaken for 5 min, as optimized, following which
saturated NaHCO3 solution was used to neutralize the reaction solution, which was then dried in
a SpeedVac at room temperature. The residue was redissolved in 3 mL H2O and desalted with
SPE columns, and the final product was eluted with 1 mL methanol. Sulfation of 5β- pregnan11β, 21-diol-3, 20-dione and 4- pregnen-11β, 20β, 21-triol-3-one occurred at C21, as indicated
by LC-MS/MS results (data not shown), leading to single products named SS427 (standing for
sulfated steroid 425, the number of which is the molecular mass of [M - H]-) and iSS427
(standing for isomer SS427), respectively; sulfation of 5α- pregnan-3α, 11β, 21-triol-20-one
happened at either C3 or C21, referred to as 3-SS429 and 21-SS429 respectively, which were
separated with a custom-packed C18 column before infusion into ESI source for MS/MS
analysis.

2.3.3 Mass Spectrometry
2.3.3.1 Electrospray Ionization Mass Spectrometry (ESI-MS):
Sample stock solutions were diluted to 1 µM and infused to an ESI source at 3 µL/min. Both
low-mass-resolving power and high-mass-resolving power ESI-MS were conducted in the
negative-ion mode on a LTQ Orbitrap Velos and a LTQ Orbitrap from Thermo Scientific (West
Palm Beach, FL), equipped with the Xcalibur operating system. Spray voltage in the negative ion
mode was set to 3.5 kV; capillary voltage and temperature was at -32 V and 275 ºC; and the tube
lens was -222 V. Tandem MS (MSn) experiments were carried out after low energy CID by using
a relative collision energy ranging from 30 to 40% of the maximum and high energy HCD with
150 eV collision energy.
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2.3.3.2 Reactive Desorption Electrospray Ionization (Reactive DESI):
All DESI experiments were carried out by using an electrosonic spray ionization (ESSI) source
to generate charged microdroplets, and a silica capillary to introduce the sample(15, 16). The ESSI
sprayer was aimed to the outlet of the sample introduction capillary at an angle of 30°-45°, and
the horizontal distance between the two was ~0.5 mm. The solvent for ESSI consisted of
methanol/water in DESI and methanol/water/5% hydroxylamine/0.05% acetic acid in reactive
DESI, and was injected at 10 µL/min, comparing to 4 µL/min of the sample flow rate. The
control DESI experiments were done in the negative-ion mode, whereas the reactive DESI
experiments were done in the positive-ion mode. The spray voltage was set at 5 kV for positive
ions and -5 kV for negative ions; the nebulizing gas (N2) pressure for ESSI was 80 psi. MS
detection was on a Thermo Finnigan LCQ DecaXP plus. Capillary temperature and voltage was
set at 250 ºC and 21 V, and the tube lens was 10 V for positive ions; they were set to 250 ºC, -47
V, and -50 V, respectively, for negative ions.
2.3.3.3 Gas Chromatography-Mass Spectrometry (GC-MS):
The sulfate group of sulfated steroids was removed by solvolysis as described in(17), under
conditions for micro-synthesis. Acidified ethyl acetate was prepared by shaking 1 M sulfuric acid
in water and ethyl acetate (V:V= 1:2) vigorously for 2-3 min and then discarding the water phase.
The dried sample was dissolved in acidified ethyl acetate to a concentration of 1 µM to give a
total of 5 mL and incubated for ~ 6 h at 38 ºC, followed by neutralization with ammonium
hydroxide. The reaction time was optimized for both SS425 and SS441 to 6 h. The desulfated
sample was then dried, and redissolved in 15 µL pyridine, to which 15 µL of N,Obis(trimethylsilyl)trifluoroacetamide (BSTFA) with 1% TMS was added and incubated at 70 ºC
for 1 h for SS425 and 2 h for SS441. Derivatized samples were then loaded into an Agilent
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(Santa Clara, CA) 7693 autosampler, and 1 µL injections were analyzed on an Agilent 7890A
gas chromatograph system interfaced to an Agilent 7200 accurate-mass Q-TOF mass
spectrometer. The samples were injected with a 10:1 split. The GC column was a DB-5MS (12 m,
0.25 mm i.d., 0.33 um film coating, P.J. Cobert St. Louis, MO). A linear temperature gradient
was used: the initial temperature of 80° was held for 2 min and increased to 280 at 15°/min. The
temperature was held at 280° for 5 min. The samples were ionized by electron ionization (EI),
and the source temperature, electron energy, and emission current were set at 280 °C, 70 eV and
300 uA, respectively. The injector and transfer line temperatures were also 280°C.

2.3.4

Hydrogen

Deuterium

Exchange

(HDX)

and

Methoxyamine

Hydrochloride (MOX) Derivatization
HDX of sulfated steroids was initiated by dissolving a dried sample in D2O, to give a sample
concentration of ~ 2 µM, at neutral pH. The same volume of acetonitrile was added prior to
conducting ESI MS and MS/MS. MOX derivatization involved 18 h incubation of dried sample
(20 µL × 1 uM) in 100 µL MOX reagent (2% in pyridine) at 60 ºC. The product solution was
then dried under nitrogen and re-dissolved in 20 µL MeOH and infused to the ESI source for
analysis.

2.4 Results and Discussion
2.4.1 Electrospray Ionization (ESI-MS), HDX, and MOX Derivatization
Given that these sulfated steroids contain a negative charge on the sulfate group, all ESI mass
spectra and product-ion spectra (MSn) spectra were obtained in the negative-ion mode to give an
[M - H]- molecular ion. High-resolving-power mass measurement gave mass accuracy within 5
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ppm for both

32

S and

34

S isotopic peaks, based on the molecular ion formulae (Table 2-1), as

expected.
Upon HDX, the molecular ion profile cleanly shifted 1 Da for SS425, indicating the existence of
one exchangeable proton in the compound.

For SS441, the shift is 2 Da, indicating two

exchangeable protons. For an unknown, its accurate mass would reveal the number of oxygens;
that number, minus those in the sulfate group, indicates the maximum number of exchangeable
sites, provided there are no nitrogens in the molecule. Under neutral conditions, hydrogens alpha
to a carbonyl group exchange very slowly and will not be “counted” here.
MOX derivatization converts the carbonyl group to an oxime (C=NOCH3), leading to an
increase of 29 Da in mass for every carbonyl of the compound.

Thus, HDX and MOX

derivatization afford a count of the number of ketone or aldehyde groups (Table 2-1 indicates
two carbonyl groups in both SS425 and SS441).
Table 2- 1. Outcomes of the application of HRMS, HDX, MOX derivatization, reactive DESI,
and HCD MS/MS of SS425 and SS441

S
(error)

S
(error)

HDX
MS
(# of
–OH)

SS425

425.1641
(3 ppm)

427.1670
(3 ppm)

426
(1)

483
(2)

491/492/493
(2)

97
(yes)

SS441

441.1584
(1 ppm)

443.1549
(3 ppm)

443
(2)

499
(2)

507/508/509
(2)

97
(yes)

Sulfated
steroids

HR/MS
Structure

32

34

MOX
deriv.
(# of
C=O)

Reactive
DESI
(# of C=O)

HCD
MS/MS
(-SO4-?)

2.4.2 Reactive Desorption Electrospray Ionization (Reactive DESI)
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As an alternative to MOX derivatization in counting carbonyl groups in sulfated steroids, we
followed Huang et al.(18) in performing reactive DESI on steroids in the positive-ion mode,
utilizing hydroxylamine and ambient-pressure ionization to derivatize steroidal carbonyl groups.
Hydroxylamine was used instead of methoxyamine because it is more volatile than the latter and
is compatible with on-line derivatization and detection. Unlike traditional DESI, we introduced
the sulfated steroid samples in a capillary with a constant flow instead of depositing them on a
plate. In this process, protonated hydroxylamine ions are formed during electrospray and carried
in microdroplets toward the substrate where they react. The proposed product ions include a
positively charged tetrahedral intermediate (hydroxylamine adduct, with a mass increase of 34
Da) and an oxime formed by loss of water from the tetrahedral intermediate (Scheme 2 in
literature(18)). Because the reaction with hydroxylamine ions give a more readily protonated
lieu
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Figure 2- 1. DESI mass spectra in the negative-ion mode for (a)
SS425, (b) SS441. Reactive DESI mass spectra in the positive-ion
mode of (c) SS425, (d) SS441.
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both in solution and in a mass spectrometer ion source operating in the positive-ion mode.
As shown in Table 1 and Figure 2-1, product ions from reactive DESI on SS425 and SS441 are
of m/z 493 and 509, respectively, both with mass increases of 68 Da, indicating the presence of
two carbonyl groups in each compound. Unlike Huang et al.’s study(18), the oxime product
wasn’t observed in either reaction, and the tetrahedral intermediate product was accompanied by
an oxidation reaction that resulted in products with 1 or 2 Da decrease in mass, such as those at
m/z 491/492 and m/z 507/508 in reactive DESI of SS425 and SS441, respectively. These
differences likely result from the different instrumentation and DESI setup (we used ESSI
instead of DESI). Although the mechanisms for the formation of the oxidized species of the
tetrahedral intermediates is not a focus of this study, a possible explanation is that the ESI
capillary (in this case, DESI capillary) is an electrolytic half-cell where redox reactions occur
under the conditions of DESI(19).

2.4.3 HCD MS/MS of ESI Produced Steroid Sulfates
Verifying the presence of a sulfate group to account for at least one sulfur atom in the
compounds is straightforward. With HCD
MS2, the product-ion spectra of SS425 and

HOSO3-, confirming that one sulfur atom is

Relative Abundance

SS441 are dominated by ions of m/z 97,

100
80

80
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40
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(Figure 2-2). Aside from the ion of m/z 97,
Figure 2- 2. HCD fragmentation of the [M –
-

the ion of m/z 80 is SO3 , offering more

H]- of m/z 425 of SS425.
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confirmation for the presence of a sulfate group. The formation of HSO4- and SO3- is expected
and was reported previously in product-ion spectra of many steroidal sulfates(20-23). The protontransfer mechanism as proposed in(24), occurs with the elimination of a ketene and a ketone.
However, other vinyl or phenyl sulfates, such as estron-3-yl 3-sulfate, do not undergo bisulfate
elimination to form HSO4- in mass spectrometric fragmentation(22, 23, 25), because that reaction
would form a prohibitively high-energy benzyne. We term the formation of the product ion
HOSO3- of m/z 97 upon HCD MS/MS as the “97” rule, which indicates the presence of a sulfate
as a signature product ion. Although HCD gives highly obvious evidence for a sulfate substituent
via the abundant product ions of m/z 80 and
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Figure 2- 3. Product-ion spectra of the [M -
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HDX.
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(presented in Figures 2-3a and 2-4a) to be
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Figure 2- 4. Product-ion spectra of the [M -

composition and the shift of 2 Da to m/z 412

H]- ions of SS441 of (a) m/z 441 (32S

in Figure 2-3b.

isotopolog) (b) m/z 443 (34S isotopolog), and

More significantly, the

(c) m/z 443 after H/DX (2H isotopolog).
product ions of m/z 325 and 343 must be
formed by losses including the sulfate groups as the m/z 325 ion now appears as both m/z 325
(losses of H234SO3 + H2O) and 327 ions (losses of H232SO3 + H2O); the latter retaining two 13C
atoms. This is consistent with accurate mass measurements for ions of m/z 343 and 325 (Table 22).
To assign with more confidence the compositions of the product ions, MS2 was also conducted
on samples where the -OH group has become deuterated (Figure 2-3c and 2-4c). By comparing
product ions in Figure 2-3a and 2-3c, or Figure 2-4a and 2-4c, any mass shift indicates, in the
absence of HD scrambling, the number of –OH groups retained in the related product ion.
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Noteworthy is the lack of any significant shifts of the m/z 325 and 343 ions (Figure 2-3c),
indicating that the loss of H2SO3 and H2O now occur as those of HDSO3 and H2O. The results
suggest that the loss of H2SO3 involves the H transfer from –OH on C11 to the sulfate group
while transferring the charge from the sulfate group to the oxygen on C11.
Table 2- 2. Calculated fragment-ion elemental compositions based on accurate mass detection of
CID fragmentations with HRMS2 for SS425 and SS441.
a. SS425

b. SS441

m/z

Calc. mass

Comp.

m/z

Calc. mass

Comp.

410.1374
343.1890
325.1785
315.1943
310.1552
297.1839
285.1475
271.1684
257.1529
241.1582
189.0911

410.1394
349.1904
325.1798
315.1955
310.1563
297.1849
285.1485
271.1693
257.1536
241.1587
189.0910

C20H26O7S
C21H27O4
C21H25O3
C20H27O3
C20H22O3
C20H25O2
C18H21O3
C18H23O2
C17H21O2
C17H21O
C12H13O2

426.1354
423.1479
411.1479
343.1909
331.1909
315.1596
313.1803
297.1487
282.1256
189.0921
138.9710

426.1354
423.1483
411.1483
343.1915
331.1915
315.1602
313.1809
297.1496
282.1261
189.0921
138.9709

C20H26O8S
C21H27O7S
C20H27O7S
C21H27O4
C20H27O4
C19H23O4
C20H25O3
C19H21O3
C18H18O3
C12H13O2
C2H3O5S
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Figure 2- 5. Sites of fragmentation for the (a) molecular ion and (b-d) various product ions of
SS425. Sites of fragmentation for the (e) molecular ion and (f-h) various product ions of SS441.
Those parts of the structures drawn in fainter lines represent the regions lost as neutrals in the
MS/MS-induced fragmentation.
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This combination of isotopic labeling
and accurate m/z measurement in the
product-ion

spectra

permits

a

Scheme 2- 1. Proposed fragmentation pathways for
(a) SS425 and (b) SS441 upon CID MS/MS. Ion
structures are consistent with fragmentation and
accurate masses of product ions, and they are

fragmentation pathway scheme to be
proposed. Those schemes (Scheme 21a and b), and reiterated in a simpler

proposed to facilitate the interpretation of the mass
spectra and are not based on standard ion-chemistry
criteria.
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characterize the steroid ring were

343

315

- H2O
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- CH4
- H2O

297

- .CH3

282

found in a MS3 experiment and are
reiterated in Figures 2-5b, c, d, f, g, and h. The fragmentation pathways proposed here for either
MS2 or MS3 are not validated by molecular orbital theory or isotope labeling. Instead, the ion
structures are proposed according to their accurate masses to be consistent with the
fragmentation. The purpose is to show correlations in the fragmentation patterns of compounds
from the same class of sulfated steroids and to provide insights on how CID fragmentation can
be applied to track functional groups and their changes on the ring. One outcome is that the ring
topology of steroid sulfates of this type can be characterized by the rich fragmentation seen in
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both MS2 and MS3 experiments, as illustrated in Figure 2-5. Collisional activation, however, does
not always produce all possible fragmentations of the ring, in which case, the specific functional
group location cannot be made. For example, the location of C17-OH in SS441 cannot be
established because there’s no cleavage for C16-C17 bond; in which case if SS441 were an
unknown compound, the –OH group can only be vaguely assigned to C16 or C17.

2.4.5 Functional Group Location based on CID MS/MS
One goal of interpreting tandem MS and accurate m/z data is to locate a functional group on the
steroid ring. The fragment ions of m/z 189 found for both SS425 and SS441 are depicted to
contain steroid rings A and B, as well as C11. The formation of ions of m/z 189 is not simply due
to the two homolytic cleavages of C11-C12 and C8-C14 bonds (scheme 2-1), but also must
involve a proton transfer from C11-OH to the weak SO3- base, possibly followed by loss of the
H2 and C9H14O5S. Although the reasoning to assign structure is similar to that used by Hsu et
al.(3),and also supported by chemical composition from accurate mass and the lack of a sulfate
group by
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S-MS2, we want to emphasize that we are not conducting a mechanism study but

rather to use pathways to study substitutions on C11. To determine whether there is a correlation
between the presence of a hydroxyl group on C11 and the occurrence of this product ion of m/z
189 in MS2, four more sulfated steroids, namely, iSS427, SS427, 21-SS429 and SS439, were
prepared, and their product-ion spectra were studied to search for similar cleavages. As expected,
three of the four compounds, all of which possess a hydroxyl group at C11, gave product ions of
m/z 189, 191 and 193 (Figure 2-6 a, b, and c), respectively, as a result of the cleavage of the C11C12 and C8-C14 bonds. By contrast, the product-ion spectrum of SS439 contains no such
product ion, theoretically of m/z 187, owing to this cleavage, because C11 is now a carbonyl
group (Figure 2-6d). Thus, we summarize this correlation between the presence of C11-OH and
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the product ion of m/z 189/191/193 as the
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Figure 2- 6. CID fragmentation in the
negative-ion mode of the [M – H]- of (a)
iSS427, (b) SS427, (c) 21-SS429, and (d)

biological relevance, is an important position

SS439.

on the steroid ring structure because it is often hydroxylated by 11β-hydroxylase during steroid
hormone synthesis in mouse, and sometimes followed by further oxidation(26). These differences
are readily detected by MS2.
Another important functional group, located at C20, is similarly deciphered by tandem MS. A
derivative of many cholesterol steroids formed in steroid hormone synthesis involves reduction
of cholesterol side-chain length and the hydroxylation of C21(13) by two important steroid
enzymes, cholesterol 20–22 desmolase and 21-hydroxylase. C20 retains a -OH or =O after C20C22 cleavage with 20-22 desmolase action(27), and hydroxylated C21 could be then sulfated by a
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sulfatase to form sulfated steroids. As a result, sulfated steroids occurring biologically often
differ at C20 as either a C=O or a C-OH. Again, this difference can be revealed by a product ion
formed by the cleavage of bond C20-C21 and loss of a neutral molecule CH2SO4 to give a
product [M - H+- 110]-, which only occurs when C20 is C=O. For example, as in Figure 2-3a, the
loss of 110 from the precursor ion of m/z 425 leads to a product ion of m/z 315 (relative
abundance of more than 20%). Accurate mass of the m/z 315 ion from HRMS2 (Table 2-2) and
34

S-MS2 (Figure 2-3b) indicates this ion forms by the loss of CH2SO4, allowing us to write an ion

structure (Scheme 2-1a). The same fragmentation occurs for SS441. More support for this
fragmentation chemistry comes from the product-ion spectra of iSS427, SS427, 21-SS429 and
SS349, for which the loss of 110 occurs for the latter three (Figure 2-6 b, c, d), all of which have
an C20 oxidized to C=O. In contrast, when C20 retains a hydroxyl group, this cleavage is
inhibited. As shown in Figure 2-6a, no obvious product ion at m/z 317 is present. Thus, we
summarize this as the “-110” rule, which addresses the correlation between C20 =O and
fragmentation C20-C21 upon CID.

2.4.6 Gas Chromatography Mass Spectrometry (GC-MS)
GC combined with EI-MS is a powerful approach for the identification of unknown compounds,
steroids being one important class of them. GC is particularly advantageous because it provides
effective separation, which is needed for the analysis of complex biological mixtures in
metabolomics. Further, EI mass spectra has always been informative in structure studies, but it
is even more so with today’s high-resolving power MS instruments that give accurate m/z for all
fragments at speeds sufficient for GC separation. Exhaustive studies were reported by others to
characterize the EI mass spectra of steroids and delineate fragmentation(28). Furthermore, online
databases of EI mass spectra have expanded tremendously during the past three decades. For
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Figure 2- 7. Mass spectra in the GC-MS mode for
derivatized (a) SS425 and (b) SS441.

for unknown sulfated steroids.
To utilize GC-MS, we had to remove chemically the sulfate group from the two standards,
SS425 and SS441, and we then derivatized the products for GC/MS analysis. Solvolytic removal
of the sulfate group was successful for nanomoles of samples, and the product yields were
greater than 50% for both SS425 and SS441 (as determined by LC/MS). Removing the sulfate
group on sulfated steroids is important for GC/MS analysis because the resulting samples are
considerably more volatile. It is noteworthy, however, that solvolysis may convolute quantitative
analysis for complex biological fluids for which a requirement may be to compare free versus
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sulfated steroids, an application
of this methodology. Accurate-mass mass spectra for SS425 and SS441 (Fig 2-7a and b) were
searched in NIST MS database. A match of corticosterone bis(trimethylsilyl) ether was found for
SS425, with a high probability score of 93%. However, no match was found for SS441.
Although this structure may appear in other databases, we turned to the EI fragmentation
pathway of SS441, based on accurate masses of fragments, to extract signature fragmentations
that assist in identification. As before, the ion structures in this scheme are not established but
only proposed to be consistent with accurate masses and fragmentation outcomes, and to
organize our conclusions on how EI fragmentation might report on the structural details of a
steroid ring. Scheme 2-2 shows that under EI fragmentation, cleavages in the ring, mostly near
the functional groups, reveal more detailed information about the ring structure. Therefore, the
rich fragmentation from EI-MS complements that from ESI-MSn, and, taken together, allows one
or several structure candidates to be proposed for an unknown.
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2.5 Conclusions
A difficulty in assigning the structures of steroid sulfate
metabolites as constituents in natural stimuli is their low
abundance, precluding the application of most structural
tools. To deal with this problem, we implemented a
combined approach including HRMS to give the
chemical formula, and HDX, MOX derivatization and
reactive DESI to count various functional groups. The

Figure 2- 8. Three fragmentation
rules of sulfated steroids under low
energy CID.

combination also includes MSn and GC-MS to resolve
the arrangement of the functional groups and ring structure. Three major fragmentation rules
were deduced in this study (Figure 2-8), the “97” rule, the “C11-OH” rule and the “-110” rule,
collectively addressing the three metabolic important carbon sites for this family of compounds
from the mouse. Proper chemical manipulation and derivatization permit the analysis of sulfated
steroids by GC-MS to take advantage of its highly effective separation and the availability of
online database searching to confirm structural assignments, taking advantage of the
complementary and rich EI fragmentation. This MS-based combined approach consumes
approximately 0.1 nmol of sample for ESI-MS with direct infusion when analyzed in the
negative-ion mode and 1 nmol was required for simple chemical modification and derivatization
for GC-MS. An outcome is that the ring topology of steroid sulfates of this type can often be
well characterized, except when an important fragmentation is missing and only vague
assignments can be made. In addition, although the fragmentation “rules” will likely change for
other classes of steroids, this approach should be general for rare steroid metabolites, affording
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one or several putative structure that can be synthesized and its MS properties compared with
those of the unknown.
Another important application may be premarin, a pharmaceutical from urine of female pregnant
horses, which is comprised of a large number of steroid sulfates, many still resisting
identification.
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Chapter 3*
High-Energy Collision-Induced Dissociation by MALDI
TOF/TOF Causes Charge-Remote Fragmentation of Steroid
Sulfates

*

This chapter is based on recent publication: Yan, Y., Ubukata, M., Cody, R. B., Holy, T. E.,
Gross, M. L.. High-energy Collision-induced Dissociation by MALDI TOF/TOF Causes ChargeRemote Fragmentation of Steroid Sulfates. J Am Soc Mass Spectrom, 2014, 25(8), 1404-11.
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3.1 Abstract
A method for structural elucidation of biomolecules dating to the 1980s utilized high-energy
collisions (~10 keV, laboratory frame) that induced charge-remote fragmentations (CRF), a class
of fragmentations particularly informative for lipids, steroids, surfactants, and peptides.
Unfortunately, the capability for high-energy activation has largely disappeared with the demise
of magnetic sector instruments. With the latest designs of tandem time-of-flight mass
spectrometers (TOF/TOF), however, this capability is now being restored to coincide with the
renewed interest in metabolites and lipids including steroid-sulfates and other steroid
metabolites. For these metabolites, structure determinations are required at concentration levels
below that appropriate for NMR. To meet this need, we explored CRF with TOF/TOF mass
spectrometry for two groups of steroid sulfates, 3-sulfates and 21-sulfates. We demonstrated that
the current generation of MALDI TOF/TOF instruments can generate charge-remotefragmentations for these materials. The resulting collision-induced dissociation (CID) spectra are
useful for positional isomer differentiation and very often allow the complete structure
determination of the steroid. We also propose a new nomenclature that directly indicates the
cleavage sites on the steroid ring with carbon numbers.
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3.2 Introduction
Steroids are among the main regulators in mammalian physiology(1), and as a result, their
metabolites are attractive candidates for conveying many aspects of an animal’s status. Steroid
sulfates were first recognized as naturally occurring metabolites in 1938 when Schachter and
Marrian(2) isolated estrone sulfate from the urine of pregnant mares. Since then, many more
steroid sulfates have been isolated from different biological sources and identified. Until the
1960s, they were considered as biologically inactive end-products of metabolism appropriate for
elimination(3). Many efforts have been made since then to search for the physiological role for
steroid sulfates, and these efforts revealed the significance of sulfated steroids for structural,
signaling and regulatory functions(4-8).That they are biologically active is made clear by the
commonly used drug Premarin, which is a complex mixture of steroid sulfates. Recently, with
the emergence of lipidomics and metabolomics, the interest in steroid conjugate analysis is again
growing. An example is the work of one of the authors (T. Holy), who found steroid sulfates of
the glucocorticoid family as “social odors” or “pheromones” in mouse urine(9, 10). Given the low
levels of these materials in mammalian fluids (at sub-micro molar concentration in mouse
urine(9)), we need improved methods for structure determinations of steroid sulfates to deal with
materials at concentrations below the levels at which NMR can be used.
In early studies of analysis of steroids and their conjugates, GC/MS with electron ionization (EI)
was the dominant approach(11-13). Although EI affords rich fragmentation, its utility is limited
because most steroids require derivatization to form volatile, thermally stable analytes(14-17),
sometimes compromising sensitivity. In the 1980s, the introduction of fast atom bombardment
(FAB)(18) and tandem mass spectrometry (MS/MS)(19, 20), afforded a new approach for structural
characterizations of steroid conjugates with mass spectrometry, but the approach required
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collision

energies

to

generate

charge-remote

fragmentation. The concept of charge-remote (originally called remote-site fragmentation) was
first described in 1983 as observed on a unique three-sector mass spectrometer(21,

22)

. This

instrumentation was later used to demonstrate the charge-remote fragmentations of a series of
bile acids and bile salt conjugates(23) and other steroids(24, 25). Tomer and Gross(26) then reported
in 1988 that both charge-remote and charge-proximate fragmentations occur for bile salts, steroid
sulfates, and glucuronides, showing that nearly complete structure determination of steroid rings
could be achieved. Unfortunately, there has been a marked decline in the application of highenergy CID with the demise of sector instruments and the current dominance of ion traps,
QTOFs, and hybrid ion-trap FT spectrometers that employ low-energy CID. Although the latter
has been applied over years in structural characterization of organic compounds, including
steroid sulfates(10, 27), the structural elucidation is complicated and incomplete because the major
fragment ions usually result from losses of small molecules, and MS3 is often required to get a
more complete set of fragment ions. Furthermore, low-energy CID spectra tend to show more
rearrangement reactions and are not as reproducible as high-energy spectra. Because low-energy
CID strongly depends on instrument characteristics and settings, the prospects of building an
MS2 database for structure searches has become more complex(28).
The introduction of TOF/TOF instruments, specifically designed for high-energy CID(29, 30), has
triggered a “renaissance” of interest in high-energy fragmentation processes. MALDI coupled to
an appropriate TOF/TOF-instrument can accommodate the need for sufficient mass resolving
power, precursor-ion selection, and high collision energies for the structural analysis of
biomolecules(31-34). The first evidence comes from Trimpin et al.(31) who showed that metalcationized fatty acids desorbed from a solvent-free preparation undergo CRF in a TOF/TOF.
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Additional evidence is from Allmeier and Pittenauer(33, 34) who induced CRF of trialkylglycerols
(TAGs). Other applications of MALDI TOF/TOF were also reported for carbohydrates and
peptides(35, 36). Whereas fatty acids have been investigated by MALDI TOF/TOF and their CID
spectra are well understood, steroids and their conjugates have been far less investigated(37). In
this chapter, we demonstrate, for the first time to our knowledge, the application of MALDI
TOF/TOF instrumentation to induce CRF and enable structural characterization of sulfated
steroids. The results are comparable to those obtained on the older tandem magnetic sector
instruments and strongly suggest that TOF/TOF instruments offer a new opportunity for lipid
and steroid structure-determination studies and for lipidomics in general.

3.3 Experimental Procedure
3.3.1 Materials
All steroids and sulfated steroids, cholesteryl sulfate, 3β-hydroxy-5-pregnen-20-one-3-sulfate
(termed SS395, for sulfated steroid 395, the number of which is the molecular mass of [M - H]-),
etiocholan-3α-ol-11,17-dione

sulfate

(SS383),

4-pregnen-11β,21-diol-3,20-dione-21-sulfate

(SS425), 4- pregnen-11β, 17,21-triol-3,20-dione-21-sulfate (SS441), 4-pregnen-17,21-diol3,11,20-trione-21-sulfate (SS439), 5β-pregnan-11β,21-diol-3,20-dione, and 4-pregnen-11β,
20β,21-triol-3-one were purchased from Steraloids Inc (Newport, RI), and dissolved in methanol
to give a 5 mM stock solution. SS427 and iSS427 were prepared by sulfating 5β-pregnan-11β,
21-diol-3,20-dione and 4-pregnen-11β,20β,21-triol-3-one as described previously(38). The
structures of all steroid sulfates used are listed in Figure 3-1. All other chemicals and reagents
were purchased from Sigma Aldrich (St. Louis, MO).
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Figure 3- 1. Structures of steroid sulfates investigated.

3.3.2 Mass Spectrometry
A MALDI-TOF/TOF mass spectrometer (SpiralTOF™, JEOL Ltd., Tokyo, Japan) was used for
all measurements. This MALDI-TOF/TOF mass spectrometer has unique multi-turn spiral ion
optics with a 17 m long flight path to provide ultrahigh mass resolving power for MALDI-TOF
measurements(39-41). An ion gate positioned at the 15 m point in the spiral ion flight path
provided mono-isotopic precursor-ion isolation for tandem mass spectrometry upon high-energy
CID(42,

43)

. Selected monoisotopic precursor ions undergo 20 kV collisions with the helium

collision gas at a pressure of 1.7x10-4 Pa. Ions exiting the collision chamber underwent 9 kV
post-acceleration and focusing to ensure efficient detection of low m/z fragments.
A 349 nm Nd-YLF laser operated at a laser repetition rate of 1 kHz was used to desorb and
ionize the samples. The extraction delay was optimized to 50 nsec. α-Cyano-4-hydroxycinnamic
acid (CHCA) matrix was dissolved in 1:1 water/acetonitrile containing 0.1% trifluoroacetic acid
at a concentration of 10 mg/mL (Trifluoroacetic acid, normally removed for the negative-ion
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mode detection, caused the signal intensity to decrease by two fold compared to its absence . It
was utilized here to show its compatibility with negative-ion mode detection and to keep open
the possibility for adoption when analyzing a biological sample mixture in both the positive- and
negative-ion modes.). The steroid sulfate and matrix solutions were mixed together 1:1 by
volume. A 1.0 µL aliquot of this mixture was deposited onto the MALDI target plate for
analysis with the MALDI-TOF/TOF mass spectrometer.

3.4 Results and Discussion
We used MALDI TOF/TOF to investigate the fragmentation of two groups of steroid sulfates,
namely 3-sulfates and 21-sulfates. These two groups were chosen because hydroxyl sites on
neutral steroids suitable for sulfonation by steroid sulfotransferase are commonly present at
carbons 3 and 21 (or 17) for C-21 steroids (or C-19 steroids). Furthermore, they have the sulfate
group fixed at either end of the steroid(44), allowing us to demonstrate the charge-remote nature
of the fragmentation. The fixed charge at one end of the precursor ion after ionization should
allow

CRF

to

be

induced

remotely as the predominant
reaction channel under highenergy CID for both 3-sulfates
and 21-sulfates. With the fixed
sulfate

group,

these

steroid

sulfates can be readily desorbed
and ionized by MALDI as [M –
-

H] species (Figure 3-2a shows

Figure 3- 2. Monoisotopic precursor-ion selection of
SS441 for TOF/TOF Measurements in Spiral TOF.
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one example of the negative-ion mass spectrum of SS441). With the SpiralTOF, accurate mass
measurements are achieved in MS1 scans, and monoisotopic precursor-ion selection is made
possible for fragmentation (Fig 3-2b), allowing straightforward interpretation of the product-ion
spectra (TOF/TOF). The major fragmentations for members of each subclass are similar and
often involve through-ring cleavages, as is described below.
Table 3- 1. Major fragment ions from high-energy CID of [M - H]- ions of 3-sulfates

Steroid sulfate

SO3- HSO3-

2,3

Cholesteryl sulfate

80,97

123

N/A

N/A

217

243

257

311

325

337

SS395

80,97

123

N/A

N/A

217

243

257

311

N/A

337

SS383

80,97

123

191

204

N/A

245

N/A

327

341

N/A

A

5,10

B

6,10

B

7,10

B

8,9

C

8,11

C

13,14

D

13,15

D

17,18

S

3.4.1 Fragmentation Nomenclature
Given that this fragmentation by through-ring cleavages may be general, we provide a new
nomenclature designating the steroid ring cleavages. Shown for cholesteryl sulfate (Table 3-1) is
the nomenclature, where each cleavage is named for the ring in which it occurs and the positions
of two carbon atoms constituting the two bonds that must be broken to cause a through-ring
cleavage (the designated carbon atoms are to the left of the cleavage, and ring A is on the left,
ring D on the right, as per convention). For example, a cleavage that breaks ring B at C9-C10
and C7-C8 is designated as 7,10B. In addition to major ring cleavages, high-mass ions are formed
by cleavages of the side chain attached to ring D, remote from the charge site (Figure 3-3).
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449
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Intensity
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379
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379
351

a
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421

393

351
365

325.1

243
257
269
283
297
240
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320

257

337

97

311
217

80

123
379

3.0

480 m/z

400

351

243

323

257
269

217
227

187

123
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1.0

denoted with a simple dashed

243

311

351

2.0
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80

(“S” refers to the side-chain).

4.0

160

337

80

97

S
Intensity

20,22

227

0.0
x105

C20-C22 is named as

175

example, the cleavage at bond

123

80

217

1.0

0.0

c

400

327

m/z

204
212

355

0.4

367

327

204

303

191
80 123

341

341

97

283

97
Intensity

0.8

80

always contains the charge.

320

245

fragmentations the charge is
fixed and the product ion

240

191

1.2

160

245

80

x105

123

line, because in charge remote

0.0

3.4.2 3-Sulfates
We investigated three steroids
substituted with sulfate at the

80

160

240

320

400 m/z

Figure 3- 3. High-energy CID fragmentation in the negativeion mode of 3-sulfates: a. cholesteryl sulfate, b. SS395, and
c. SS383. The highly broadened [M – H]- signals indicate
this precursor is off scale presumably because the production yield is low and dispersed over many fragments.

3-position (A ring) by MALDI
TOF/TOF and obtained highly informative MS/MS data, with rich fragmentation occurring
through the steroid ring (Table 3-1). As indicated in the product-ion spectra (Table 3-1 and
Figure 3-3), 3-sulfates undergo predominantly charge-remote fragmentation upon high-energy
collisions, providing information about the nature of the substituent and its location, especially if
the substituent is an alkyl chain. Taking cholesteryl sulfate as an example, we find rich
fragmentation of the ring structure and the side chain at C17 (Figure 3-3a) to give a detailed
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“foot-print” of the ring junctions and the side-chain branching of this compound. For example,
the mass difference for the B-ring cleavage, 7,10B, and the C ring cleavage, 8,9C, is 26 Da, which
corresponds to C2H2 and shows that the ring junction is unsubstituted. Comparing the three 3sulfates, we find that processes 2,3A, 8,9C, and 13,14D occur for the three compounds, and the mass
differences between 2,3A and

8,9

C are 120 Da (C9H12) for cholesteryl sulfate and SS395 whereas

for SS383, the difference is 122 Da (C9H14), consistent with the absence of a double bond in the
latter. Similarly, the differences between

8,9

C and

13,14

D are consistent with the substitution

patterns (Table 3-1 and Figure 3-3). For cholesteryl sulfate and SS383, the differences between
13,14

D and

13,15

D are 14 Da, as expected whereas for SS395, the

13,15

D fragment is missing, and

replaced by an ion m/z 323 formed by loss of C4H8O by an unknown mechanism. On the
contrary, the appearance of product ions from cleavages across the B ring are significantly
different for SS383 and the other two, mainly because the C5-C6 bond is a single bond for
SS383 and a double bond for the other two (Figure 3-3 a, b). A fragment ion is formed by the
nearby cleavage,

7,10

B, of both cholesteryl sulfate and SS395, although this fragment is missing

in the product-ion spectrum of SS383 (Figure 3-3c). Besides B-ring cleavages, cleavages of the
C ring show the expected differences among the three compounds. For example,

8,11

C is absent

in SS383 fragmentation, consistent with the presence of the C11 keto group that prevents this
cleavage (Table 3-1), and the differences between

8,9

C and

8,11

C for cholesteryl sulfate and

SS395 is 14 Da, consistent with a CH2 group at position 11. This detailed analysis of ring
cleavages was not presented in the early papers on CRF of steroids, and the prospects for a
nearly complete structural analysis were not understood. Importantly, branching sites on the side
chain are easily determined by examining the pattern for CnH2n+2 eliminations, because cleavages
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happening at either side of a branch point are more facile than those occurring via double
cleavages at a branch point.
Table 3- 2. Major fragment ions from high-energy CID of [M - H]- ions of 21-sulfates

Steroid
2,3

A

1,3

A

1,4

A

5,10

B

6,10

B

7,10

B

8,9

C

8,11

C

8,12

C

13,14

D

13,15

D

17,20

S

20,21

S

sulfate
iSS427

383

371

N/A

317

303

291

263

235

221

180

167

139

110

SS427

383

371

357

315

301

288

261

233

219

178

165

N/A

110

SS425

381

369

N/A

315

301

289

261

233

219

178

165

N/A

110

SS441

381

367

N/A

331

317

305

N/A

N/A

235

N/A

N/A

139

110

SS439

395

383

N/A

329

N/A

303

N/A

N/A

235

N/A

181

139

110

Note: * All 21-sulfates produce fragment ions at m/z 80 and 97, representing SO3- and HSO4- respectively.
** 2,3A and 1,3A product ions from SS441 associated with a consecutive lost of H2O, as revealed in m/z.

In addition to the common fragment ions due to ring or side-chain cleavage, some unexpected
fragments are also formed; these are consistent with our early findings on CRF of steroid sulfates
(26)

. For example, besides the losses of neutral molecules in which the C17 substituent is cleaved

with H-transfer, cleavages also occur to eliminate directly a CH3 radical, presumably forming a
distonic ion, rather than H transfer and elimination of neutral molecules (this cleavage is termed
17,18

S, as shown in Table 3-1). The mechanism for this cleavage was previously proposed to

occur through a six-member transition state (Scheme 1 in ref 26). Although obtaining detailed
mechanistic data is not the purpose of this paper and must await future work, we show the
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fragmentation for clarity. Another example is the fragmentation of the three 3-sulfates to undergo
a CH4 loss upon CID. This process most likely arises from the loss of an angular methyl group
(C18 or C19) with H rearrangement and indicates the presence of methyl substituents.

3.4.3 21-Sulfates
We investigated five different compounds with different substitutions on the ring or the side
chain, as listed in Table 3-2. Similar to 3-sulfates, 21-sulfates give rich charge-remote
fragmentation as cross-ring cleavages and of the side chain upon high-energy CID (Figure 3-4).
Ions of m/z 80 and 97 are also abundant in product-ion spectra of 21-sulfates, representing
SO3- and HSO4- from releases of small, charged sulfur-containing groups. Although we adopted
x10 6
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Figure 3- 4. High-energy CID fragmentation in the negative-ion mode of 21-sulfates:
a. iSS427, b. SS427, c. SS425, d. SS441, and e. SS439. The highly broadened [M –
H]- signals indicate this precursor is off scale presumably because the product-ion
yield is low and dispersed over many fragments.
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the same nomenclature for all the cleavages of 21-sulfates as for the 3-sulfates, the designations
for 21-sulfates are of portions of the steroid that are lost as neutrals whereas for the 3-sulfates,
they are part of the fragment ion. The scheme in Table 2 shows an example of the cleavages of
SS427.
The CID spectra of [M - H]- ions can be used to delineate clearly the locations and type of
different substitutions. For example, the positional isomers, iSS427 and SS427 differ in the
position of a double bond; iSS427 has the double bond between C4 and C5, whereas SS427 has
the unsaturation located at C20 as a keto group. As a result, their product-ion spectra (Figure 3-4
a, b) show that ions formed by

1,4

A cleavage are among the most abundant fragments formed

from SS427 but undetectable for iSS427. The same types of fragmentations involving rings B, C,
and D occur for both compounds, but they show a consistent mass shift of 2 Da. In addition, the
C20 keto groups in SS427 and in SS425 (Figure 3-4 b, c) prevent the

17,20

S cleavage, but

replacement of the keto group with C20-OH in iSS427 promotes this fragmentation and gives the
ion of m/z 139 (Figure 3-4a). An m/z 139 ion is observed, however, although less abundant, in
the product-ion spectra of SS441 and SS439 (Figure 3-4 d, e), indicating that the effect of a C20
keto group on

17,20

S is eased when substituted by a hydroxyl group at C17 (the only difference

between SS441 and SS425). Although SS441 differs from SS425 only by the C17 hydroxyl
group, it undergoes fewer cleavages of the C and D rings, suggesting that a C17 hydroxyl group
suppresses cleavages of the C and D ring. Likewise, SS439 also undergoes nearly no cleavages
across the C and D ring under CID.
Expulsions of neutral molecules, CH4 or CO, are dominant reactions for most 21-sulfates being
studied. The loss of CH4 is similar to that in 3-sulfates, which likely involves an angular methyl
group. Loss of CO is also a charge-remote cleavage on the A ring of 21-sulfates, which occurs
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similarly at the D ring of SS383, a 3-sulfate steroid. The other two 3-sulfates undergo no such
fragmentation owing to the lack of keto groups on the ring system. Besides losses of CH4 and
CO, SS441 also gives abundant ions by the loss of H2O, which are followed by other consecutive
fragmentations such as 2,3A and 1,3A, as indicated in Table 3-2.
We wish to note that the cleavages are not always as simple as indicated by the dashed lines.
Sometimes the cleavage occurs as designated (e.g.,

1,3

A,

1,4

A,

7,10

B,

8,11

C,

8,12

C, and

13,15

D)

whereas other cleavages occur as designated but are accompanied by additional H transfer(s).
Consider, for example,

2,3

A. A simple through-ring cleavage would give loss of C2H2O, but the

actual fragmentation is to lose C2H4O.The mechanistic reasons for these differences are
interesting and remain to be elucidated. Nevertheless, structural assignments can still be made in
the absence of a complete understanding of the ion chemistry.

3.4.4 Approximate Detection Limits
In addition to studying the effectiveness of MS/MS fragmentation for structure elucidation, we
evaluated the detection limit of the 3- and 21-sulfates on this MALDI TOF/TOF instrument,
requiring sufficient fragmentation information for structure characterization. We took one
example from each group of steroids, cholesteryl sulfate and SS425, and evaluated the signal-tonoise ratio (S/N) of the base peaks in their product-ion spectra when different amounts of sample
were applied to the MALDI plate. As shown in Table 3-3, S/N of the base peak at m/z 311 in the
product-ion mass spectrum of cholesteryl sulfate decreased from 200 to 80 when the applied
sample amount is reduced from 25 pmol to 4 pmol. Further reduction of the sample applied to 1
pmol caused the S/N for detecting the ion of m/z 331 to decrease to 20. Although the intensity for
the base peak detection is still acceptable with 1 pmol of sample application, some of lowerabundance product ions disappeared below the S/N at this condition (e.g., the ion of m/z 217),
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making a structure assignment incomplete. Similarly, for SS425, S/N of the base peak at m/z 219
decreased from 500 to 60 in the product-ion spectrum when the sample applied was decreased
from 25 to 1 pmol; further, the lower abundance fragment ions began to disappear with 1 pmol of
sample application. Although the S/N tracks only approximately the applied sample quantity, we
can conclude that the approximate detection limit sufficient for structure assignment of steroid
sulfates is low pmol levels, with some variations for different samples. This low sample-size
requirement demonstrates the applicability of MALDI TOF/TOF for analyzing biological
samples where only trace amounts can be isolated (e.g., SS425 was shown to exist in mouse
urine at micro-molar concentrations in a previous study(9)).
Table 3- 3. Signal-to-noise ratios of base peaks in the product-ion spectra of
cholesteryl sulfate and SS425 as a function of the amount of sample applied.
Steroid sulfate

Cholestery sulfate

SS425

311

219

Base peak (m/z)
Applied amount (pmol)

25

10

4

1

25

10

4

1

S/N

200

100

80

20

500

400

200

60

3.5 Conclusion
The effectiveness of charge-remote-fragmentation for primary structure identification of lipids
and steroids has been known for some time. The approach can determine locations of double
bonds, identify various functional groups, locate branching and ring junctions directly from
product-ion spectra. Instrumentation and ionization methods traditionally used for CRF,
however, have become rare, diminishing the importance of CRF in structural studies.

It

continues to be recognized and invoked, however, as one class of fragmentation, a “thermal-like”
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process that occurs with little or no involvement of a charge or radical site. Low-energy MS/MS
fragmentation of steroid sulfates(45) produce fewer cross-ring cleavages and is less informative
than the spectra from high-energy activation, which induces extensive fragmentation across the
steroid ring at the ring junctures.
The ability to induce CRF coupled with the advantage of monoisotopic precursor-ion selection
afforded by new TOF/TOF instruments, permits relatively straight-forward interpretation of
product-ion spectra because all product ions are monoisotopic. These characteristic ions formed
under high-energy CID are nearly identical to those observed many years ago on tandem sector
instruments when the sample was introduced by FAB ionization. Cleavages through the steroid
rings occur whether the steroid is a 3- or a 21-sulfate, consistent with the classification that the
processes are “charge-remote” as would be expected because the intervening rigid steroid ring
makes it impossible for the charge site to interact with the reaction site. Although the earlier
measurements on steroids proved that the fragmentation is indeed charge-remote and showed the
nature of the remote side chain, the work in this chapter also shows that there is more
information in these spectra (e.g., on ring junctions and substituent locations).
In spite of the commonality of ring cleavages, 3-sulfates can be easily differentiated from 21sulfates by the low m/z product ions. For example, 3-sulfates give a product ion of m/z 123 by
2,3

A cleavage, whereas 21-sulfates give product ions of m/z 110 arising from the side-chain

cleavage,

20,21

S. 3-Sulfates containing alkyl side chains on the D ring can also be differentiated

from 21-sulfates, because the former is rich in fragments in the high mass range, owing to
cleavages of the side chain, to give product ions that reflect its structure and locate the branch
points. Locating functional groups is also straightforward by considering the mass differences
between nearby cleavages. An important caveat is that certain substitutions on the ring (e.g., a
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C11 keto group) can prevent nearby fragmentations. In this case, the absence of cleavages is also
informative and should be taken into account when elucidating unknown steroid structures.
We project that an important application of this approach will be in imaging steroids, lipids, and
related materials.
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Chapter 4
Structural Characterization of A Novel Steroid Metabolite:
A Molecular Code for Identity in the Vomeronasal System
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4.1 Abstract
In social interactions, individuals are recognized by visual, auditory, or olfactory cues, but the
fundamental basis of recognition is poorly understood. Olfactory recognition exploits emitted
chemical cues, but identifying the key signals among thousands of compounds remains a major
challenge. To address this need, Holy et al. developed a new technique, Component-Activity
Matching, to select candidate ligands that “explain” patterns of bioactivity across diverse
complex mixtures. Using this technique, 23 components from mouse urine were found as
candidates to explain firing rates in seven of eight functional classes of vomeronasal sensory
neurons. And one putative female sex pheromone, was identified to stimulate a class of neurons
selective for females. This compound accounted for much of the neuronal activity of some
female strains, and greatly enhanced investigatory behavior of males. Here, we report the
structural characterization of this unknown compound. Mass spectrometric approaches, including
high-resolution mass spectrometry, HDX and other chemical derivatization followed by ESI
mass spectrometry, and tandem mass spectrometry are used to identify this compound, which we
named as cortigynic acid. The structural identity of the compound is later confirmed with custom
synthesis based on the proposed structure.
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4.2 Introduction
Mammals explore the chemical world with several olfactory modalities(1). The accessory
olfactory system (AOS) emphasizes the detection of social cues, sometimes called pheromones,
which regulate behavior among members of the same species(2, 3). Behavioral data have shown
that pheromones are present in several scent sources: secretory glands (lacrimal, salivary, and
preputial), urine, and feces(2, 4). Mouse urine excites widespread activity among vomeronasal
sensory neurons (VSNs)(5-8) and is the best behaviorally characterized source of chemical cues
for mammalian social communication(2). Although recent progress has been made toward
identifying the molecular nature of pheromone cues by purifying individual ligands from mouse
urine(9-11), the identities of olfactory ligands inside urine cues are largely unknown.
Recently, Holy lab developed a novel approach, Component-Activity Matching (CAM), for
systematically and exhaustively defining a “short list” of candidate vomeronasal ligands that
encode identity. This approach exploits the striking differences among natural stimuli across
different sexes and strains of mice(8) in a forward screen for compounds that may drive activity in
vomeronasal neurons, without the need for laborious sample purification. The hypothesis is that
these different neuronal activity patterns could be caused by different ligands present in one or
more of urine samples. Thus, the molecular correlates of identity might therefore be discoverable
by seeking compounds whose abundance could “explain” these patterns of physiological
responses. Using this approach, a small set of constituents whose concentrations match a pattern
of neuronal responsiveness across samples were identified. Later, they focused on a class of
neurons that responded to urine from females of all strains, which did not respond to any male
strains. One best CAM candidate that explains this pattern of neuronal activity was purified. It is
proven to account for one-fourth of neuronal activity of female C57BL/6J mouse urine.
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In this chapter, we report the structural characterization of this best CAM candidate, which we
call M377, with mass spectrometry. Different mass spectrometry methods are used, including
high-resolution MS, tandem MS and HDX MS. Based on the proposed structure, a standard
compound was custom-synthesized and used to confirm the identity of the unknown compound.
Preliminary behavior studies indicate that this M377 (cortigynic acid) is a sex pheromone that is
unique in female mouse urine. The identification of its strucuture introduces a new type of
molecular cues for identity in a mammalian olfactory system.

4.3 Experimental
4.3.1 Materials
1, 4-pregnadien-11β, 17, 20-triol-3-one 21-carboxylic acid were purchased from Steraloids inc
(Newport, RI), All other chemicals and reagents were purchased from Sigma Aldrich (St. Louis,
MO).

4.3.2 Hydrogen/Deuterium Exchange (H/DX)
H/DX of M377 was initiated by dissolving a dried sample in D2O at neutral pH, to give a sample
concentration that, based on ion count of similar structures, was ~ 2 µM. The same volume of
acetonitrile was added prior to conducting ESI MS.

4.3.3 Periodic Acid Reaction
The periodic acid reaction with M377, as well as a comparison standard 1, 4-pregnadien-11β, 17,
20-triol-3-one 21-carboxylic acid (Steraloids, Newport, RI), was initiated by mixing 20 µL of
sample (~1 µM in MeOH) with 80 uL of 0.5% periodic acid. The reaction mixtures were then
shaken for 20 minutes before nanoLC/MS analysis.
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4.3.4 Mass Spectrometry
Stock solution of M378 and synthetic compound was diluted to ~1 µM and infused to an ESI
source at 3 µL/min. ESI-MS were conducted in both the negative-ion mode on a LTQ Orbitrap
Velos and the positive-ion mode on a LTQ Orbitrap from Thermo Scientific (West Palm Beach,
FL), equipped with the Xcalibur operating system. In the negative ion mode, spray voltage was
set at 3.5 kV; capillary voltage and temperature was at -32 V and 275 ºC; and Tube lens was 222 V. In the positive ion mode, spray voltage was set at 4.5 kV; capillary voltage and
temperature was at 49 V and 250 ºC; and Tube lens was 100V. Tandem MS (MSn) experiments
were carried out after low energy CID by using a relative collision energy ranging from 30 to
40% of the maximum.

4.4 Results and Discussion
4.4.1 Chemical Formula
Deduction of M377 with High
Resolution MS
High-resolution mass spectra (HRMS) and H/DX mass spectra were
obtained

to

determine

elemental

composition and the presence of
particular chemical groups. HR-MS in
the

negative-ion

mode

gave

an

Figure 4- 1. HRMS mass spectra for M377 (A) in the
negative ion mode (B) in the negative ion mode after
HDX (C) in the positive ion mode after HDX.
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accurate mass of 377.1968 for molecular ion [M-H]- (Figure 4-1A), consistent within 1ppm with
the formula C21H29O6−. This chemical formula is also supported by the isotopic peak distribution,
with the

13

C peak being ~20% of the

12

C peak. H/DX MS was performed in both negative and

positive ion modes, showing that the maximum mass shift after hydrogen/deuterium exchange is
3Da in negative ion mode and 4 Da in positive ion mode. This indicates that there are four
exchangeable sites (hydroxyl groups) in the molecule, of which one gets ionized in the negative
ion mode for detection, suggesting the presence of a carboxylic group (Figure 4-1B and C).

4.4.2 Structural Characterization of M377 with Tandem MS
For further structural elucidation of M377,
low-energy

negative-ion

collision-induced-

dissociation (CID) spectra were acquired at
both low and high resolving power (Figure 42A and B), allowing elemental composition to
be calculated for product ions (Table 4-1). For
example, one of the product ions at m/z
189.0922 is calculated to be (C12H13O2−), with
mass accuracy within 1ppm. Interestingly, this
product ion was also observed in a previous
study

, so here we performed MS3 on this

(11)

product ion. The result (Figure 4-3A) showed
Figure 4- 2. CID fragmentation in the
negative ion mode of (A) M377, (B) M377
with accurate mass detection, and (C) 4pregnadien-11β, 16, 20-triol-3-one 21carboxylic acid.

3

an identical MS spectrum. Thus, the ion of
m/z 189 (C12H13O2−) has the structure depicted
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in Scheme 4-1. Another example is one of
product ions at m/z 331.1909 (C20H27O4−)
(Figure 4-3B), formed by the loss of CH2O2 by
cleavage of the C20-C21 bond. This fragment
ion supports our hypothesis of a -COOH group
at this position. Similarly, an ion of m/z
301.1805 (Figure 4-3C) is attributed to the loss
of C2H4O3, from the cleavage of the C17-C20
bond, which could be explained by a
consecutive C20-CH(OH)- group next to the
C21–COOH group. This interpretation is also
supported by the MS3 data of ions at m/z 331,
Figure 4- 3. MS3 in the negative ion mode of
(A) product ion at m/z 189 from M377 MS2
(B) product ion at m/z 331 from M377 MS2
(C) product ion at m/z 301 from M377 MS2.

which led to fragment ions at m/z 301 (Figure
4-3B). Also, given the known structure of the
ion of m/z 189 (C12H13O2−), the fragment ion

of m/z 203 (C13H15O2−) can be assigned as the cleavage in C ring which differs by one carbon
site from that producing m/z 189. Similarly, fragment ions of m/z 243 (C16H19O2−) and m/z 257
(C17H21O2−) were formed by cleavages of the D ring. When compared to ions of m/z 189, this
indicated that there were no –OH group substitutions on C12, C13, C14 or C15 (Scheme 4-1).
Thus, the location of each functional group can be assigned as indicated in Scheme 4-1, with one
exception: the –OH group located either on C16 or C17. Based on the difference (C2H4O) of
product ions of m/z 257 and 301, the cleavage sites that led to them can only be separated by two
carbons, C16 and C17, one of which bears the last unassigned –OH group. This interpretation is
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also supported by MS3 analysis of an ion of m/z 301 (Figure 4-3C), which showed an abundant
Table 4- 1. High-resolution Mass Measurements of Major Fragment ions.
measured mass (Da)

calculated mass (Da) elemental composition Elemental composition
of ion
of lost molecule

377.1963

377.1970

C21H29O6-

N/A

359.1857

358.1864

C21H27O5-

H2O

331.1909

331.1915

C20H27O4-

CH2O2

313.1804

313.1809

C20H25O3-

CH4O3

301.1805

301.1809

C19H25O3-

C2H4O3

295.1699

295.1704

C20H23O2-

CH6O4

287.1648

287.1653

C18H23O3-

C3H6O3

269.1543

269.1547

C18H21O2-

C3H8O4

257.1544

257.1547

C17H21O2-

C4H8O4

243.1388

243.1391

C16H19O2-

C5H10O4

203.1078

203.1078

C13H15O2-

C8H14O4

189.0922

189.0921

C12H13O2-

C9H16O4

161.0975

161.0972

C11H13O-

C10H16O5

fragment of m/z 257. However, due to the lack of additional fragmentation between the C16 and
C17, MS2 gave little indication of which of these locations should be preferred. Therefore, we
carried out a chemical degradation with periodic acid, which reacts with 1,2-diols by cleaving the
C-C bond and forming an aldehyde. Consequently, periodic acid would react with M377 if the –
OH was on C17 (forming a 1,2-diol at C17 and C20), but not if the –OH was on C16. Both
M377 and a standard compound 1, 4-pregnadien-11β, 17, 20-triol-3-one 21-carboxylic acid
(P0750-000, Figure 4-4A) were reacted with periodic acid. P0750-000 served as a positive
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control, and the chemical derivatization products were detected by positive-ion mode MS. As
expected, P0750-000 reacted with periodic acid and generated a reaction product of m/z
301.1798 (C19H24O3)+ (Figure 4-4A). In contrast, M377 did not react with periodic acid, with
only the unreacted [M+H]+ of m/z 379.2115 present (Figure 4-4B). Therefore, we confirmed that,
unlike P075-000, M377 has a 1,3–diol instead of a 1,2–diol. Since C20 has a –OH group (as
described above), the unassigned –OH group must be positioned at C16 instead of C17.
Therefore, we proposed the structure of M377 to be 4-pregnadien-11, 16, 20-triol-3-one 21carboxylic acid, also known as 16-hydroxycorticosterone 20-hydroxy-21-acid.
To test the validity of this structural interpretation, we obtained a custom synthesis of this
proposed compound, as a epimeric mixture at carbon 20. Product-ion mass spectra of the
synthetic and endogenous compounds are nearly indistinguishable (Figure 4-2A and C), and MS3
on major MS2 fragment ions from both compounds are also consistent (data not shown),
indicating identical structures of the two. Further, the two stereoisomeric components of the
synthetic epimeric mixture were quantified by HPLC as having a concentration ratio of 10:1; of
which the less abundant component matched the endogenous compound in elution time and
Scheme 4- 1. Fragmentation processes proposed for the [M-H]- ion of M377.
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showed

the

same

neuronal

activity as endogenous M377.
The structure of M377 has
several distinctive features. To
our

knowledge,

biological

activity of a steroid carboxylic
acid has not been previously
reported.

As

a

21-carbon

steroid with a hydroxyl group at
the 11th position, this structure
likely derives from metabolism
of

a

glucocorticoid(12).

Figure 4- 4. HRMS mass spectra for products of periodic
reaction with (a) 1, 4-pregnadien-11β, 17, 20-triol-3-one
21-carboxylic acid, (b) M377.

However, the hydroxyl group at
position 16 is a motif characteristic of a female sex steroid, estriol, which in humans is only
produced in significant amounts during pregnancy(13). We therefore named this new VSN ligand
“cortigynic acid.”

4.5 Conclusion
The structural elucidation of M377 as a vomeronasal code for identity helped support the newly
developed strategy, CAM, as a validated fast unbiased screen for VNO ligands. Without
requiring any purification, CAM identified a single compound, out of 1,634 possibilities, to
explain responses of a neuronal type selective for urine from BALB/c females. Structural
analysis of this compound, M377, to be a novel ligand, cortigynic acid. One of the most
intriguing aspects of this structure is the presence of a hydroxyl group on C16, a motif known
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from the estrogen compound estriol. Unlike the C17 position, a hydroxyl group at C16 is less
common among urinary metabolites. One possible source for the enzymatic activity that adds
this hydroxyl to C16 of a steroid is a P450 16 hydroxyl enzyme(14). In fact, this 16α-hydroxylase
activity in mouse liver microsomes was found in many female inbred mice, including the
BALB/c and C57BL/6J mouse strains used in our current study.
Preliminary behavioral study showed cortigynic acid to be a potential first cue for encoding
“sex” from urinary cues for the mouse vomeronasal system. Cortigynic acid was present at high
concentration only in intact adult female mice urine, and was relatively constant across strains. In
behavioral tests, cortigynic acid substantially and significantly increased male investigatory
behavior. When added to male urine, this one ligand increased the duration of investigation bouts
by more than two-fold. Based on results with a close structural analog, we speculate that the
specific interest in this compound integrates multiple structural features, including the 16hydroxyl moiety specific to female mice. This is the first known female-selective ligand in
mouse urine. These results take a major step towards a comprehensive understanding of the
molecular code for identity in the vomeronasal system.
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Chapter 5
Introduction: Protein-Protein Interactions,
Hydrogen/Deuterium Exchange, Fast Photochemical
Oxidation of Proteins for Mass Spectrometry-Based Protein
Biophysics
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5.1 Abstract
Knowledge about the structural and biophysical properties of proteins when alone or in
complexes with other ligands in solution is important in understanding many biological
processes. Such knowledge is also needed for therapeutic drug development. Recent evolution
and improvement of MS-based approaches are making it powerful for the study of protein
chemistry. Two most popular MS-based protein footprinting strategies are hydrogen deuterium
exchange and fast photochemical oxidation of proteins, which enable the study the biophysical
properties of proteins in solution as well as their interactions with binding partners. The
principles of these two techniques are introduced in this chapter as a prelude to the Chapter 6 and
7, where we report their application in some protein biophysics studies.
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5.2 Protein-Protein Interaction
Protein-protein interactions (PPIs) play a central role in regulating many biological processes.
The interactions are fundamentally characterized as stable or transient, both of which can be
weak or strong. The most common stable protein interactions are between the subunits of a
protein complex, which in many cases can now be isolated and purified. The transient
interactions often require changes in conditions, such as phosphorylation or external factors that
affect conformations, to trigger the interaction. When in contact with their binding partners,
transiently interacting proteins control many cellular processes(1), including protein modification,
transport, folding, signaling, and cell cycling.
Proteins bind to each other via a combination of chemical forces, including van der Waals forces,
hydrophobic interactions, and salt bridges. The binding interfaces could occur over large surfaces
spanning hundreds of residues or be represented by a small peptide formed by proteolysis. The
binding affinity is influenced by, but not limited to, the types of interaction and the size of the
binding domain. Other factors, such as ionic strength, pH, and presence of other ligands, may
also affect the binding affinity.
Malfunction of the protein-protein interactions can result in disease(2, 3). Because PPI plays a
significant role in life cycles, considerable efforts have been made to discover what features of a
protein are “druggable”; and modulation of PPI has emerged as a promising strategy to treat
human diseases and is receiving growing attention by the scientific community. Many of the
drugs on the market were developed by using these principles, and they treat a multitude of
diseases.
As the foundation of drug design, PPI and its understanding are key to drug development. In
recently years, the technologies to characterize protein-protein interactions have rapidly matured,
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one of which being mass spectrometry-based approaches(4). These methods not only facilitate
drug development, but also help to improve our knowledge in biological networks.

5.3 MS-Based Protein-Protein Interaction Studies
A common strategy that is adopted in mass spectrometry-based methods for investigating the
conformational properties of proteins in solution is to introduce covalent modifications into
proteins and use ESI or MALDI MS, often coupled with separation, to read out the results(5).
More specifically, this strategy involves measuring the labeling reaction rate at local regions of a
protein to ascertain information about the
local

solvent

accessibility

and

conformation. This approach can probe
protein

conformational

changes

associated with protein-protein or proteinligand interactions and protein dynamics.
In the last decade, a variety of different
covalent labeling techniques have been

Figure 5- 1. Three types of hydrogens in
proteins. (1) black: amide hydrogens; (2)white:
hydrogens attached to sidechain functional
groups; (3) hydrogens bonded to carbons.

developed and applied in this area of study(6-8). The work described here in the second part of the
thesis focuses on two covalent labeling methods combining with MS in studying protein
biophysics, namely, hydrogen deuterium exchange (HDX) and fast photochemical oxidation of
proteins (FPOP).

5.4 Hydrogen Deuterium Exchange
Hydrogen deuterium exchange measures the integration of deuterium into a protein(s) by relying
on the natural phenomenon of hydrogen exchange. It was traditionally used in conjunction with
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NMR analysis(9), and its use with MS was implemented shortly after the development of ESI(10,
11)

. Important developments in HDX MS have followed through the years(7, 12-19), now it is well-

established and more useful than expected in protein biophysics studies, offering unparalleled
limits of detection, low sample consumption, and the promise of single amino-acid resolution.
HDX monitors the exchange rate of amide hydrogens on the protein backbone. There are three
types of hydrogens(20) in the protein, namely the amide hydrogen, the hydrogens attached to the
functional groups of side chain, and the hydrogens covalently bonded to carbon (Figure 5-1(21)).
The exchange rates of these three types of hydrogens are significantly different. Hydrogens
attached to the functional groups of side chains exchange fastest (half lives of ms), and are easily
back-exchanged to hydrogen in HDX by returning the protein to a protic solvent. On the contrary,
hydrogens bonded to carbon atoms are essentially not exchangeable with deuterium in D2O. The
exchange rate of amide hydrogens is in the middle (half lives of seconds to hours); therefore,
they are measurable on a lab time-scale. The characteristics of HDX allow us to measure readily
the extent of deuterium uptake of amide hydrogens on the backbone and monitor protein
dynamics.

5.4.1 Effect of pH and Temperature on HDX rates
The HDX reaction can be catalyzed by either acid or base. Thus, the rate of HDX is sensitive to
pH -- one unit change in pH leads to ten-fold change in the exchange rate(22). Although the
intrinsic exchange rates of backbone hydrogens are different and dependent on solvent
accessibility and hydrogen bonding, the overall exchange rate reaches the slowest value near pH
2.5 (Figure 5-2A). Furthermore, like most other reactions, temperature also affects the rate of
HDX(23, 24), which decreases ten-fold by lowering temperature from room temperature (25 ºC) to
0 ºC at pH 2.5. Therefore, HDX can be “quenched” by adding acidic solution to the exchanging
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medium to bring down its pH to 2.5 while cooling in ice water. This slows considerably back
exchange and allows capture of the HDX information while conducting digestion and MS
analysis. The use of quench conditions is important because analysis of the deuteration is almost
always performed in protic media. After the quench, the overall half life of HDX is longer but
still much shorter than other covalent labeling strategies. Therefore, MS analysis following HDX
is often kept short, within approximately10 min, to minimize the amount of back-exchange and
yet obtain sufficient deuterium uptake to assure reliable measurement of it.

Figure 5- 2. The rates of H/DX depend on pH (A) and temperature (B). Taken
from HXMS website: http://www.hxms.neu.edu/research/tutorial_theory.htm

5.4.2 Exchange Kinetics of HDX (EX1 vs. EX2)
Key to the application of HDX in structural studies is that conformational properties of the
protein modulate the N-H to N-D conversion rate. Two important factors limiting HDX of amide
sites are hydrogen bonding and solvent protection. In protected regions, the overall rate constant
kHDX is much smaller than kch, which is the rate constant for exchange in unstructured peptides.
Nevertheless, those buried amide hydrogens can still undergo HDX with measurable rates by
exchanging during short-lived, transitional “open” conformations, which are created by
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conformational fluctuations of the protein. Such structural fluctuations can either be determined
globally or localized for a protein segment by conducting proteolysis prior to analysis. The
model for most hydrogen exchange of native proteins in D2O is:

N − Hcl ⇌ N-Hop → N − D
kch

Eq. 5-1

kcl

where kop is the rate constant of protein unfolding/opening motion and kcl is the rate constant of
protein folding/closing motion. Eq. 5-1 is typically discussed with two limiting regimes referred
to as EX1 and EX2(25, 26).
EX1 is characterized by kch >> kcl, so that kHDX is given by the unfolding/opening rate constant:
kHDX = kop. EX1 kinetics can be seen as a cooperative unfolding event involving several residues
in a protein region, all of which exchange before refolding/closing. In such situations, the protein
or protein regions give multiple groups of deuterium uptake distribution after HDX, making data
interpretation difficult.
EX2 is characterized by kch << kcl, leading to kHDX = (kop/kcl)kch. Under this condition, the
probability of HDX occurring during a single opening event is small, many opening/closing
cycles may occur before an isotope exchange happens on a given amide. Proteins undergoing
this behavior show a single major group of deuterium uptake distribution after HDX in the mass
spectra and that distribution broadens and moves to higher m/z with time of exchange. Under
physiological conditions, most proteins, including those discussed in this thesis, undergo EX2
exchange kinetics and only a few undergo EX1 kinetics naturally. Intermediate cases that exhibit
aspects of both regimes are also known(26, 27).
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5.4.3 HDX MS-Based Protein Structure and Dynamics Study
Continuous labeling is the strategy most often applied in studying protein structure, dynamics,
and interaction. In continuous labeling, a native protein is exposed to D2O, and the deuterium
uptake level is monitored as a function of exchange time (often ranging from seconds to hours).
As the exchange time increases, the extent of deuterium labeling gradually increases in the
protein. Protein regions that spend more time in open conformations undergo faster exchange
than those more tightly folded. Based on Eq. 5-1, HDX primarily monitors protein structural
dynamics, and dynamics is closely connected to protein structure (folded regions are generally
less dynamic than disordered regions).
Because deuterium is one unit in mass higher than hydrogen, the amount of D incorporation can
be calculated by measuring the mass increase of a protein/peptide after HDX. Therefore, the
relative D uptake level can be calculated by Eq. 5-2:
D% = {[m(P) – m(N)]/[m(F) – m(N)]} × 100%

Eq. 5-2

where m(P), m(N) and m(F) are the centroid values of partially deuterated protein/peptide,
nondeuterated protein/peptide, and fully deuterated protein/peptide, respectively. By plotting D%
against T (time), a HDX kinetic curve for protein/peptide is generated, and can be used for
comparison among different states.
HDX kinetics can be measured either at the global level or, more commonly, at the peptide level.
Peptide-level analysis is especially important because protein conformational changes occur at
small regions, such as at protein-protein interaction site, where one may seek to locate the
specific interface with higher spatial resolution than observing changes at the global level. HDX
coupled with enzymatic digestion (using acidic proteases) prior to mass spectrometry analysis
affords such peptide-level resolution. Subsequently, similar analysis with HDX kinetic curves at
94

Figure 5- 3. H/DX workflow that provides “peptide-level” information. Taken
from Chalmers et al. 2011. Expert Review Proteomics.
peptide-level can be used to compare among different states (i.e., apo vs. holo) to locate the
regions that undergo conformational changes (i.e., protection) in different states (Figure 5-3).
Residue-level HDX analysis is sometimes performed with electron-transfer dissociation to refine
the spatial resolution to the amide level. However, this application is difficult and limited by
instrumentation and fragmentation efficiently. It is not considered further in this thesis.
Today, HDX MS is widely used in protein biophysics and in drug development, such as epitope
mapping, protein-stability studies, and protein-ligand binding studies (for reviews, see(28-30)). For
a protein-protein interaction study, usually two treatments of the protein, bound and unbound, are
prepared and subjected to continuous labeling. The kinetic curves of most abundant peptides
from both treatments are plotted together and compared, as depicted in Figure 5-3. Regions that
undergo no conformational change upon binding will show no difference in extent of deuterium
incorporation. Regions that show significant protection against D labeling are likely to be located
at or near the binding interface.
Furthermore, this traditional continuous labeling technique, HDX MS-based ligand binding and
protein stability experiments can be used in other applications. For example, Gross et al.(31-34)
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developed a method for monitoring protein-ligand interactions by MS, titration and hydrogen
deuterium exchange (PLIMSTEX). PLIMSTEX curves show the amount of exchanged
hydrogens against ligand concentration at a fixed exchange time. From the shape of the curve,
binding affinity and stoichiometry can be uncovered through least-squares fitting analysis of the
PLIMSTEX titration curve. Fitzgerald and coworkers(35-42) developed a method in studying
protein stability, namely, stability of unpurified proteins from rates of HD exchange (SUPREX).
SUPREX uses denaturant to affect protein thermodynamic stability, and its curves display the
number of exchanged hydrogens as a function of denaturant concentration for a fixed exchange
time. SUPREX profiles have a sigmoidal appearance resembling unfolding curves as measured
by optical methods. These two methods are not applied in studies in this thesis, and therefore are
not further discussed.

5.5 Fast Photochemical Oxidation of Proteins
The concept of applying oxidative
labeling

coupled

with

MS

footprinting in protein biophysics
study is very similar to that of
continuous

labeling

HDX

Cross
Section
of Laser
Beam

Section of fused
150 µm silica flow
tube, with flow
controlled by
syringe pump

MS.

However, more elaborate means than
248 nm

HO

OH

2 HO

just sample dilution with a solvent
are required to initiate the labeling
reaction. Oxidative labeling utilizes

Figure 5- 4. Flow system for Fast Photochemical
Oxidation of Proteins (FPOP). The frequency of the
pulsed laser beam and the sample flow rate are
adjustable to control the single labeling of the sample.

hydroxyl radicals, which can be
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generated by different means, to react with certain amino acids in the protein(43-46). Fast oxidative
labeling (millisec time scale) was first established by Chance and coworkers(44) by radiolytic
modification. Photochemical labeling initiated by laser irradiation of H2O2 was later developed
by different groups(47-49). Of those methods, only fast photochemical oxidation of proteins
(FPOP), developed by Hambly and Gross(49), uses a flow system and controls the radical life to ~
1 µs by introducing a radical scavenger to prevent excessive labeling (Figure 5-4).
FPOP labeling monitors protein conformation and solvent accessibility by exposing the protein
to hydroxyl radicals for a short (~ µs) time and measuring the modification extent. In an FPOP
experiment, the sample is mixed with 15 mM of H2O2 and a chosen radical scavenger
(conventionally 20 mM of Gln), and then flowed through a silica tube (ID: 150 µM) which has a
clear window facing laser irradiation (Figure 5-4). The laser is a pulsed 248 nm KrF laser and its
frequency is adjusted along with the sample flow rate in order to avoid double shots of the same
sample fraction. Upon irradiation, H2O2 is photolyzed to form hydroxyl radicals, which then
reacts with the scavenger and the protein. The presence of the scavenger controls the radical life
time to ~ µs, and, therefore, the protein sample is only shortly exposed to the hydroxyl radicals.
Because of this short exposure and fast reaction, only one single state, which is often the native
state, of the protein is “captured” and labeled. As a result of the sampling of a single
conformation of the protein, the labeling products (+0, +16, +32 etc. Da states) present in a
Poisson distribution(50). Other developments with FPOP involves using different radicals (e.g.,
SO4-• and I•) to react with different amino acids; such developments expanded the original
design of FPOP and demonstrates its versatility. In this thesis, however, we only discuss FPOP
labeling in protein-protein interaction characterization with the original •OH design.
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The resulting modification of an amino acid reacting with hydroxyl radicals is generally thought
to be independent of the technique used for radical production(51-53). Intrinsic reactivity of the
functional groups in proteins with hydroxyl radicals have been extensively studied over the
years(43-46). Previous studies showed that 14 of the 20 common amino acids in the protein react
with hydroxyl radicals(43) (these commonly modified residues and their corresponding reaction
rate constants are listed in Table 5-1. The oxidation products are numerous, but the most
common modification is +16 (+oxygen or substitution of an H by an OH). One example of a
hydroxyl radical reaction with an amino acid is shown in Figure 5-5. Besides labeling the side
chain of the protein amino-acid residues, hydroxyl radicals can also nonspecifically cleave
protein backbones. However, such cleavages occur 10-1000 times slower than side-chain
modifications(43, 44, 46), and they can be further minimized by modifying labeling conditions.
Table 5- 1. Rate Constants for Reaction
of 14 Amino Acids with Hydroxyl
Radical at near Neutral pH. Take from
Chance et al. 2005 Anal. Chem.
substrate
Cys
Trp
Tyr
Met
Phe
His
Arg
Ile
Leu
Val
Gln
Lys
Ser
Glu

rate (M-1s-1)
3.5 × 1010
1.3 × 1010
1.3 × 1010
8.5 × 109
6.9 × 109
4.8 × 109
3.5 × 109
1.8 × 109
1.7 × 109
8.5 × 108
5.4 × 108
3.5 × 108
3.2 × 108
2.3 × 108

pH
7.0
6.5-8.5
7.0
6-7
7-8
7.5
6.5-7.5
6.6
~6
6.9
6.0
6.6
~6
6.5

Figure 5- 5. Reaction of hydroxyl radical
with phenylalanine. Taken from Chance et
al 2007 Chem. Rev.
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FPOP experiments rely on peptide mapping with high-resolution LC/MS and MS/MS to identify
the site of modification in a protein/peptide. Unlike HDX, hydroxyl radical labeling is
complicated and heterogeneous at different residues and/or sites of a protein; therefore,
performing MS/MS on the digested modified peptides is important for identifying the
modification. Because •OH labeling is irreversible, complex sample handling, such as long
digestions and LC/MS analysis, can be performed. Nevertheless, data interpretation remains
difficult. There is now some commercial software available for identifying modification type and
calculating the modification extent; however, they are far from perfect and a lot of manual
examination is still required after software data processing.

5.6 The Complementary Roles of HDX and FPOP
Both HDX and FPOP footprinting have the advantage of probing protein conformations in the
solution-phase with no known protein size limit. These experiments can provide a
comprehensive picture of biological change related to conformational changes as affected by
mutation(54, 55), aggregation(56, 57), and ligand binding(58-60).
Both HDX and FPOP labeling methods have their relative strengths and weaknesses. For
example, HDX labeling is reversible and, therefore, requires rapid, low-temperature digestion,
separation and MS analysis, which sometimes limits the number of protein identifications
especially with complex samples having undergone post-translational modification. On the other
hand, FPOP labeling does not require specialized LC-MS-based strategies to preserve the label
because it is irreversible and, therefore, is more flexible to accommodate complex sample
treatment and LC-conditions tuning to achieve as complete as possible peptide identification and
good sequence coverage. However, FPOP labeling has the difficulty of being heterogeneous in
both labeling subjects and products, generating products with varied molecular weights and
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retention times in the LC-MS readout. Thus, FPOP imposes considerable more difficulty on data
analysis. HDX labeling is homogeneous, and its data analysis is much easier.
HDX and FPOP labeling provide complementary information to each other on protein
conformations. For example, FPOP labeling is very fast whereas HDX labeling is relatively
slow. In footprinting, short labeling time can be advantageous in probing low-amplitude motions
that occur on fast timescales, but at the same time, short labeling limits the range of solutionphase conformations that can be probed, which becomes less of a problem for longer labeling
times. Besides labeling speed, HDX and FPOP labeling also provide orthogonal information
regarding the labeling subjects. HDX labeling occurs on the protein backbone, while FPOP
targets the protein side-chains. Therefore, they may identify conformational changes caused by
different interactions.
In the second part of this thesis, we present the application of both HDX and FPOP labeling to
study protein structure and dynamics. In chapter 6, we studied the dimerization of SecA protein
with HDX MS. The controversial interface was solved along with new findings of accompanying
conformational changes upon dimerization, which provided leads for the active form of SecA. In
chapter 7, we focus on mapping the epitope of Adnectin1-EGFR interaction at amino acid
residue level by FPOP. The epitope identified agrees with that from both HDX study and
crystallography results, presenting more evidence of the capability of FPOP in epitope mapping.
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Chapter 6*
Hydrogen Deuterium Exchange Mass Spectrometry for the
Analysis of SecA Dimerization in Solution

*This chapter is based on recent publication: Wowor, A. J., Yan, Y., Auclair, S. M., Yu, D.,
Zhang, J., May, E. R., Gross, M. L., Kendall, D. A., Cole, J. L.. Analysis of SecA Dimerization
in Solution. Biochemistry, 2014, 53(19), 3248-3260. (Yan, Y. and Wowor, A. J. contributed
equally to this work.)
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6.1 Abstract
The Sec pathway mediates protein translocation across the inner membrane of bacteria. SecA is a
motor protein that drives preprotein translocation through the SecYEG channel. SecA reversibly
dimerizes under physiological conditions but different dimer interfaces have been observed in
SecA crystal structures. Here, we have used biophysical approaches to address the nature of the
SecA dimer that exists in solution. We have taken advantage of the extreme salt sensitivity of
SecA dimerization to compare the rates of hydrogen-deuterium exchange of the monomer and
dimer and compared the result to the study of effects of single alanine substitutions on
dimerization affinity performed by our collaborators in U Connecticut. Our results support the
antiparallel dimer arrangement observed in the crystal structure of Bacillus subtilis SecA.
Additional residues lying within the preprotein binding domain and the C-terminus are also
protected from exchange upon dimerization, indicating linkage to a conformational transition of
the preprotein binding domain from an open to a closed state. In agreement with this
interpretation, normal mode analysis demonstrates that the SecA dimer interface influences the
global dynamics of SecA such that dimerization stabilizes the closed conformation.
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6.2 Introduction
In bacteria, the majority of secretory preproteins are translocated through a general secretion
(Sec) pathway that contains a Sec translocase complex comprising the integral membrane
channel, SecYEG, and the cytosolic ATPase motor protein, SecA(1, 2). SecA binds preproteins,
associates with the SecYEG channel, and harnesses energy from ATP hydrolysis to drive
conformational changes that lead to preprotein
translocation(3-6).

SecA

is

a

large,

102

kDa

multifunctional protein that is comprised of several
domains: nucleotide binding domains I and II (NBD I
and II), a preprotein binding domain (PBD), and a Cdomain that is comprised of an α-helical scaffold
domain (HSD), an α-helical wing domain (HWD) and
a carboxyl-terminal linker (CTL) (Figure 6-1)(7). The
PBD and HWD contribute to the formation of a
binding groove for the signal peptide region of the
preprotein(8-12).
SecA exists in a monomer-dimer equilibrium that is

Figure 6- 1. Structural domains of
SecA. The structure of E. coli SecA
(PDB 2VDA(8)) with domains
indicated by color: NBD I (blue),
PBD (purple), NBD II (green), HSD
(red) and HWD (cyan). In this
monomer structure the PBD adopts
an open conformation.

sensitive to salt concentration and temperature(13-16). The cellular concentration of SecA is 5-8
µM(17, 18), and its dissociation constant is 0.28 µM in 200 mM KCl(16). Thus, in the absence of
ligands, SecA likely exists as a dimer in the cytoplasm(13, 16). It has been suggested that SecA
functions as a dimer during preprotein translocation because a cross-linked SecA dimer(19, 20) and
a genetically produced SecA dimer(21) are active for translocation. Nevertheless, the oligomeric
state of SecA during preprotein translocation remains controversial. Some studies indicate that
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dissociation of SecA is favored in the presence of phospholipids(18,

22)

or synthetic signal

peptides(23), and upon SecYEG binding(24). Other reports support an active monomeric form of
SecA, indicating that the monomeric SecA mutant is functional(25) whereas a disulfide crosslinked dimer is nonfunctional and its reduced monomeric counterpart is functional(26).
The relative positioning of the two protomers in the SecA dimer is also unclear. Although the
structure of the SecA protomer obtained from different bacterial species is highly conserved in
crystal structures, multiple dimeric interfaces have been identified(27-31) among the five crystal
structures of the SecA dimer reported to date (Figure 6-2). Both parallel(29) and antiparallel(27, 28,
30, 31)

dimer orientations are observed and these structures contain different dimerization

interfaces. For example, the dimer interface of Escherichia coli SecA (PDB 2FSF(31)) lies on the
opposite side relative to the dimer interface in one of the Bacillus subtilis SecA structures (PDB
1M6N(27)). It is difficult to distinguish crystal packing contacts from biologically relevant
protein-protein interfaces(7, 32, 33), and it remains unclear which of these crystal structures, if any,

Figure 6- 2. Alternative dimer interfaces in SecA. The dimer interfaces in different structures
of SecA are indicated in blue with the protomers in two orientations. A) E. coli SecA (PDB
2FSF)(31), B) T. thermophilus (PDB 2IPC)(29), C) B. subtilis (PDB 1M6N)(27), D) B. subtilis
(PDB 2IBM)(30), and E) M. tuberculosis (PDB 1NL3)(28). The cyan circles in B and C indicate
the location of the N-terminal region.
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corresponds to the physiologically relevant SecA dimer. Single particle cryo-electron
microscopy measurements support an antiparallel dimer structure(14) and fluorescence resonance
energy transfer distance measurements show the greatest agreement with the 1M6N antiparallel
dimer(34, 35). A cross-linking study led to the proposal of a novel interface that involves residues
from the NBD I, PBD, and HSD(36).
Interestingly, the PBD is found to adopt multiple conformations. A closed form that brings the
PBD and HWD in close proximity is found in several SecA dimer crystal structures(27-29) and in a
structure of a SecA monomer complexed with ADP(37), whereas an open conformation where the
PBD is solvent accessible exists in a crystal structure of a monomeric form(38) and in one dimer
structure(31). In the open state, the groove between the PBD and NBD II forms a polypeptidebinding clamp(24, 39). Binding of a non-signal sequence peptide in this region results in movement
of the PBD towards NBD II(37). Interaction of SecA with SecYEG induces further movement of
the PBD towards NBD II, closing the clamp(24). NMR analysis indicates that SecA interconverts
between open and closed states in solution, with the equilibrium favoring the open state(8).
Cysteine cross-linking indicates that movement of the PBD from the open state to the closed
clamp state is required for initiation of translocation(40).
To resolve these conflicting interpretations, we collaborated with Prof. James Cole’s group in U.
Connecticut and combined three biophysical strategies to identify the dimer interface of SecA in
solution and to characterize the conformational changes associated with dimerization. First, we
used hydrogen/deuterium exchange mass spectrometry (HDX MS) to identify regions on SecA
that are protected from exchange upon dimerization and to probe conformational changes
associated with dimerization. Second, to complement our result from HDX and achieve sitespecific information on the dimer interface, our collaborators from U. Connecticut selected
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amino acids for alanine substitution that are predicted to have significant energetic contributions
to SecA dimerization based on alternative dimer interfaces. Each alanine-substituted protein was
then analyzed by sedimentation velocity analytical ultracentrifugation (AUC) to measure SecA
dimerization affinity. Third, Prof. Eric May from U. Connecticut performed normal mode
analysis of SecA monomer and dimer and defined conformational changes linked to
dimerization. This combined strategy locates the likely SecA dimer interface and provides a link
between closure of the PBD/HWD groove and SecA dimerization. In this chapter, we will focus
on the discussion of our study on HDX MS. For details of the other two methods, one can refer
to the publication.

6.3 Materials and Methods
6.3.1 Wild-Type SecA Expression and Purification
Wild-type, native E. coli SecA was expressed and purified as previously described(16). SecA
samples were exchanged by using spin columns into a working buffer containing 20 mM 4-(2hydroxyethyl)-1-piperazineethanesulfonic

acid

(HEPES)

(pH

7.5),

0.5

mM

ethylenediaminetetraacetic acid (EDTA), 0.1 mM tris(2-carboxyethyl)phosphine (TCEP), and
100 to 500 mM KCl. The SecA concentration was determined by absorbance at 280 nm, using a
molar absorptivity (ɛ280) of 75,750 M−1 cm−1 calculated with Sednterp(41).

6.3.2 HDX MS Protocol
Given the high sensitivity of SecA dimerization to salt concentration (Kd increases from 0.014
µM at 100 mM KCl to 40.4 µM in 500 mM KCl(16)) , this effect was exploited to permit
comparison of HDX of SecA dimer (low salt) and monomer (high salt). Stock solutions of
untagged, wild-type SecA were prepared at 6 µM in either low salt (100 mM KCl) or high salt
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(500 mM KCl) pH 7.5 buffer, each containing 20 mM HEPES, 0.5 mM EDTA, and 0.1 mM
TCEP. Samples were equilibrated at 25 °C for 1 h before HDX analysis. Continuous labeling
with deuterium was initiated by diluting 4 µL of the stock solution into 16 µL of D2O with an
identical KCl concentration. Based on the measured dissociation constants, the low salt samples
were 93% dimer, and the high salt samples were 95% monomer. HDX was measured at 10 s, 30
s, 1 min, 2 min, 15 min, 1 h, and 4 h. Two proteases, pepsin and fungal XIII, were used for
protein digestion to achieve high peptide coverage. For measurement, the exchange reaction was
quenched at various times by mixing with 30 μL of 3 M urea, 1% trifluoroacetic acid (TFA) at
~1 °C. The mixture was then passed over a custom-packed pepsin column (2×20 mm) at 200
µL/min. For fungal XIII digestion, the exchange reaction was quenched with 30 μL of 1.2
mg/mL fungal XIII, 1% formic acid (FA) in water and set on ice for 2 min. Prior to LC/MS
analysis, the digested peptides were captured on a 2×15 mm C8 trap column (Agilent, Santa
Clara, CA, USA) and desalted with a 3 min flow at 200 μL/min of H2O containing 0.1% TFA.
Peptides were then separated by using a 2.1×50 mm reversed-phase C18 column (1.9 μm
Hypersil Gold; Thermo Fisher Scientific, Waltham, MA, USA) with an 11.5 min linear gradient
of 4%–40% CH3CN in 0.1% FA at 50 µL/min with a nanoACQUITY UPLC (Waters, Milford,
MA, USA). Protein digestion and peptide separation were carried out in water-ice bath to
minimize back exchange. MS detection was performed on an LTQ-Orbitrap (Thermo Fisher
Scientific, Santa Clara, CA, USA) with the following instrument parameters: spray voltage 4 kV,
capillary temperature 225 °C, capillary voltage 44 V, and tube lens 100 V. Data were collected
with mass resolving power of 100,000 at m/z 400. Each experiment was carried out in duplicate.
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6.3.3 HDX Data Analysis
To identify the products of pepsin or fungal XIII digestions and to provide a list of peptides to be
followed during HDX, product-ion mass spectra were acquired in a data-dependent mode, with
the six most abundant ions from each scan selected for MS/MS. The MS/MS *.raw files were
then converted to mzXML files and submitted to MassMatrix for peptide identification(42). This
search was also performed against a decoy (reversed) sequence, and ambiguous identifications
were discarded. The final peptide list generated from MassMatrix was output as *.csv files.
The peptide list *.csv files and Thermo *.raw files were then input into HDX workbench(43) to
calculate the centroid masses of isotopic envelopes (m) and deuterium level (D%). As described
previously(44), D% = {[m(P) – m(N)]/[m(F) – m(N)]} × 100%, where m(P), m(N) and m(F) are
the centroid values of partially deuterated peptide, nondeuterated peptide, and fully deuterated
peptide, respectively. The retention time window used for calculation of m of each peptide in
each sample was manually inspected and adjusted for accurate calculation of D%, and peptides
that showed interference by isotopic peaks from other peptides were discarded. The deuterium
level was finally adjusted because the exchange media had 80% deuterium content. The data
were not corrected for back exchange because two states were compared.
For details on SecA mutagenesis, analytical ultracentrifugation, and normal mode analysis,
please see Biochemistry, 2014, 53(19), 3248-3260.

6.4 Results
6.4.1 Experiment Condition Control for HDX
Because the oligomeric state of SecA depends on the KCl concentration, and the intrinsic
exchange rate of amide protons are largely unaffected by different salt concentrations(45), we
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prepared samples of SecA containing predominantly monomer or dimer—at the same protein
concentration—by simply varying the KCl concentration. Any measured changes in HDX rates
would then reliably reflect any dimerization-induced changes in the protein. We previously
determined that the Kd for SecA dimerization at 20 °C varies from 0.014 µM at 100 mM KCl to
40.4 µM at 500 mM KCl(16). We also found that Kd decreases monotonically by approximately a
factor of two for every 5 °C increase in temperature; thus, at 25 °C, where we conducted HDX,
the Kd values of SecA in 100 mM KCl and 500 mM KCl are approximately 0.007 and 20.2 µM,
respectively. For each incubation in our continuous HDX experiments, the SecA stock solution
was diluted from 6 µM to 1.2 µM with D2O buffer. Under these conditions, 93% of the SecA is
dimeric at 100 mM KCl and 95% is monomeric in 500 mM KCl.
To obtain high coverage of SecA in the digestion following HDX, we supplemented the
traditional pepsin digestion with a separate one using acidic protease, fungal XIII. Pepsin
digestion alone gave 86% coverage; missing were 35 residues at the N-terminus and 30 residues
at the C-terminus. Fungal XIII digestion, however, allowed us to recover many peptides covering
the N-terminus. Combining the peptides from the two digestions provided high (96%) coverage
for the total 901 amino acid residues in this large protein.

6.4.2 HDX Analysis of SecA Monomer
We expect that regions on the protein with defined secondary structures will undergo slower
HDX than unstructured regions or those in loops. This is because protein backbone amide
hydrogen exchange rates are highly dependent on local fluctuations in structure and solvent
accessibility(46). We mapped for visual convenience the HDX results for the SecA monomer onto
the NMR structure of E. coli SecA (PDB 2VDA). The time-dependent deuterium uptake for the
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SecA peptides from pepsin and fungal XIII digestion, measured at seven time points, was used in
the mapping (Figure 6-3).
In general, the peptides located completely in α-helical or β-sheet regions exhibit slower HDX (<
40% at short time points) and are more protected than those at loops and termini. One exception
is the peptide covering residues 602-609. Although this region is an α-helix in the NBD II
domain, it is dynamic with over 70% of the amide hydrogens exchanged after 10 s. Judging from
the NMR structure, we see that this helix is located at the periphery of the NBD II domain and is
detached from the main body by two loops, imparting greater solvent accessibility and more
frequent local conformation fluctuations to this region. Noticeably, the N-terminus peptides
covering residues 1-6 and 7-15 were also found to be highly dynamic, with maximal exchange
within 10 s. When looking at different exchange behavior from 10 s to 4 h, most of the peptides
contained within α-helical or β-sheet regions underwent increases of less than 40%. Interestingly,

Figure 6- 3. HDX dynamics of SecA monomer. Different color indicates
different amount of D uptake.
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unlike most others, peptides derived from the long α-helix in HSD covering residues 627-666,
showed an increase to more than 80% in deuterium uptake. This may reflect the relatively higher
dynamics of this α-helical region, also named the “transducer helix(47)” , which, as indicated by
its name, is important for allosteric communication between NBD I , NBD II, PBD, and the Cdomain(37).

6.4.3 Differential HDX Analysis of SecA Monomer and Dimer
To determine the dimerization interface of SecA, we applied comprehensive differential HDX
analysis of the monomer and dimer. In this approach, the HDX kinetics of peptic/fungal peptides
derived from the SecA monomer and dimer were compared (percentage-of-deuteriumincorporated, D%, versus time (log scale) plots are made for all peptides). As expected, some
regions in the dimer became more protected against exchange than in the monomer. The average
differences in D% (ΔD%) for the duplicate analysis of seven exchange time points were
calculated, and regions with significant differential deuteration levels are identified in Table 6-1.
The differences between the monomer and dimer in these regions are considered significant
because all peptic and fungal peptides covering the same region showed consistent HDX
kinetics, smooth curves, and similar ΔD% values. These regions are categorized into two groups:
those that show a large difference (ΔD% ≥ 6, red) and those that show a small difference (3 <
ΔD% ≤ 5, magenta). It is worth mentioning that most regions in SecA have insignificant ΔD%
values (less than 3; not listed in Table 6-1). For example, Figure 6-4D shows some HDX kinetic
plots of regions that are unaffected by SecA dimerization. This consistency over most regions in
SecA serves as a negative control in showing that the HDX rate is unaffected by KCl
concentration and indicates there are large regions of the protein that show little change in HDX
upon dimerization.
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Table 6- 1. SecA peptides showing different deuterium level incorporation induced by dimerization.
Region Structure
208-216

NBD

313-319

PBD

320-338

PBD

350-374

PBD

375-380

NBD

398-408

NBD

427-437

NBD2

562-574

NBD2

575-587

NBD2

626-671

HSD

672-690

HWD

701-708

HWD

723-737

HWD

744-757

HWD

758-774

HSD

775-783

HSD

815-830

HSD

Pepsin Digestion
AA Position
208-215 (+1)

Δ D%
3

314-319 (+2)
315-320 (+2)
320-325 (+2), 320-326 (+1)(+2)
321-326 (+1)(+2)
327-333 (+1)(+2), 327-334 (+2)
359-372 (+2), 360-372 (+2)
359-368 (+2), 359-374 (+2)
373-380 (+1)(+2)
375-380 (+1)
399-404 (+1)
401-409 (+2)
404-409 (+2)
432-437 (+1)
432-437 (+2)

4
6
13
15
8
13
13
5
3
9
6
4
4
4

572-586 (+3)(4)

5

627-638 (+2), 627-638 (+4)
627-638 (+3)
627-639 (+3)
639-647 (+2)(3), 648-666 (+4)
627-647 (+3)(+4), 649-666 (+4)

8
11
8
6
5

685-690 (+1)(+2)
701-706 (+1), 701-708 (+1)(+2)
701-707 (+1)(+2)
723-730 (+1)(+2), 731-737 (+2)
724-730 (+2)
744-755 (+2)(+3), 746-758 (+2)(+3)
746-755 (+2)(+3), 748-755 (+2)(+3)
747-755 (+2)(+3), 746-757 (+2)(+3)
758-767 (+3), 759-767 (+2)(+3)
759-765 (+3)
768-774 (+1)
775-781 (+2), 775-782 (+2)(+3)
775-783 (+2)
815-820 (+2)
815-826 (+2), 816-826 (+2)
821-826 (+1)

4
3
4
4
7
5
7
6
3
4
3
6
8
4
4
5

Fungal XIII Digestion
AA Position
208-215 (+1), 210-215 (+1)
211-217 (+1)
313-319 (+2)
320-325 (+2)
320-326 (+1)(+2)
327-338 (+2)

Δ D%
3
5
3
13
13
7

352-358 (+2), 350-362 (+2)(+3)
350-358 (+2),363-368 (+1)
369-379 (+2)
373-379 (+1)
398-408 (+2), 399-407 (+2)
399-408 (+2)
402-407 (+2), 402-408 (+1)(+2)
427-434 (+2), 427-436 (+2)
430-436 (+2)
562-568 (+3)
569-574 (+2)
567-587 (+4), 569-587 (+3)(+4)
569-585 (+3), 569-586 (+3)(+4)
626-633 (+2), 626-635 (+2)(+3)
634-639 (+1)(+2), 654-660 (+2)
636-642 (+3), 661-666 (+2)
659-665 (+2)
664-671 (+1)
672-677 (+1)
683-689 (+1)(+2), 683-690 (+2)

15
12
5
5
6
6
7
5
3
6
12
5
5
10
11
8
10
6
4
4

724-732 (+3)
724-733 (+2)(+3)
744-750 (+2)(+3)
744-751 (+3)

3
4
7
5

762-768 (+2), 765-771 (+1)
762-771 (+2), 764-771 (+2)
772-778 (+2)(+3)
772-783 (+3)

4
3
3
8

812-819 (+2), 814-819 (+2)
820-826 (+1)
820-828 (+1)(+2), 820-830 (+2)

4
2
3

The ΔD% values represent the average difference in percentage of deuterium incorporation across all HDX exchange
points of SecA monomer and dimer. The red and magenta colors represent two groups categorized based on ΔD%
values: large and small, respectively. The values in parentheses represent the charge state of each peptide ion; two values
indicate two charge states for the same peptide.
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In contrast, several regions that show significant ΔD% values (Table 6-1) must have different
structures or interactions in monomer and dimer states. The largest differences are observed for
peptides within the region 627-671 in the HSD (Figure 6-4A) and within the regions 313-338
and 350-374 in the PBD (Figure 6-4B). Peptides encompassing 758-774 and 815-830 in the HSD
show small changes of ΔD% but a large difference is detected for 775-783 (Figure 6-4C). The
kinetic curves for monomer and dimer typically come together at long times, suggesting that the
dimer has a relatively large off rate, allowing the protomer to be freed from the dimer and
undergo HDX as the monomer.
To help understand the interface that forms upon SecA dimerization, we mapped the regions

Figure 6- 4. Peptide-level HDX kinetics of SecA. A comparison between monomer
(black) and dimer (red) shows significant changes in HDX at the transducer helix
from HSD (A), regions in PBD (B), two helix fingers from HSD (C), and no
differences in HDX at regions undergoing little structural change (D). The
corresponding regions for A, B, and C are marked on Figure 6-5A.
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identified in Table 6-1 onto the NMR structure of SecA using the same color code (Figures 6-5A
and B). The three locations exhibiting the greatest difference in HDX (Figures 6-4A, B, and C),
are marked with a’, b’ and c’, respectively, on the structure shown in Figure 6-5A. Region a'
corresponds to the long transducer helix in HSD. Region b' lies within the PBD and includes two
antiparallel β-strands and the following α-helix. Region c’ contains the two-helix finger from
HSD. Other regions within HWD, NBD I, and NBD II also show some differential ΔD% and are
highlighted in Figure 6-5.
The regions of SecA that show reduced HDX upon dimerization lie on multiple faces of the

Figure 6- 5. Structural analysis of SecA HDX kinetics. A and B: exchange rates
mapped onto the E. coli SecA (PDB 2VDA) structure. Regions exhibiting a large
difference (ΔD% ≥ 6) are colored red and regions exhibiting a small difference (3 <
ΔD% ≤ 5) are colored magenta, as in Table 6-1. A) Ribbon diagram. Regions marked
as a’, b’, and c’ correspond to peptides in Figures 6-4A, B, and C, respectively. B)
Surface representation. C and D: exchange rates mapped onto the closed-form model
of E. coli SecA. C) Dimer structure. Coloring of the left protomer corresponds to A
and B. D) Interface of the PBD and the C-domain.
122

protomer surface, suggesting that large conformational changes accompany dimerization. Using
the crystal structure 1M6N as a reference, we attribute the decreased HDX in the transducer helix
(region a') to dimer-interface formation; this is also consistent with our AUC results described
below. We assign the decreased HDX in the PBD (region b') to an induced allosteric effect
caused by dimerization. Corresponding HDX changes are also evident within region c' and the
HWD, supporting a model where SecA dimerization induces movement of the PBD into a closed
conformation where it interacts with the C-terminal portion of SecA. This model is consistent
with the previous observation of open and closed conformations of the PBD(14, 27, 30, 37, 38, 48, 49). In
the closed conformation, the PBD interacts extensively with the C-terminal domain and forms a
compact structure, whereas in the open conformation, the PBD is more solvent exposed and
would, therefore, undergo a greater extent of HDX. Owing to its vicinity to the transducer helix,
the altered HDX in the two-helix finger may arise from dimerization or altered interactions with
the PBD. The small ΔD% of the short peptide 427-437 located in NBD II opposite the HSD may
be due to an allosteric effect.

6.4.4 Analysis of the SecA Dimer Interface by AUC
To complement our analysis of the dimer interface by HDX, our collaborators from U.
Connecticut used AUC to probe the energetic contribution of individual surface residues to SecA
dimerization. Residues observed within the dimer interfaces of SecA crystal structures from
multiple bacterial species(27-31) were chosen to be substituted with alanine. The program
Robetta(50) was used to identify residues lying within potential dimerization interfaces and to
guide selection of single alanine substitutions that are expected to strongly destabilize the SecA
dimerization. AUC was then used to measure the dissociation constants of the alanine mutants.
The result showed consistency with our HDX data, indicating two residue from HSD, Q662 and
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E665, significantly affect SecA dimerization. Besides that, the AUC result also showed that
another residue from the N-terminus, K8, is important to SecA dimerization as well, which was
unrevealed in HDX results.
To analyze further the effect of N-terminus on SecA dimerization, deletion constructs, including
∆2-8, ∆2-9, and ∆2-10, were examined. And the result showed that SecA dimerization decreases
with the number of residues deleted from the N-terminus. SecA constructs containing multiple
alanine substitutions at the N-terminus were also generated and examined. And they found that
dimerization affinity decreases as additional alanine substitutions are introduced.
For more details on this section, please see Biochemistry, 2014, 53(19), 3248-3260.

6.4.5 Normal Mode Analysis
To explore the possibility of an allosteric
mechanism in which SecA dimerization mediates
structural changes, Prof. Eric May from U.
Connecticut performed normal mode analysis on
the monomer and dimer in the open and closed
states. The analysis showed that the major
structural difference is related to the separation
between the PBD and HWD regions (Figure 6-6),
and the dimer has a mode that couples much more
strongly to the PBD-HWD domain separation than
any mode in the monomer. The presence of this
mode, which does not appear (as a single mode) in

124

Figure 6- 6. Normal mode analysis of
SecA monomer and proposed dimer
configurations. The open state (PDB
2VDA) is shown as a surface
representation in gray and the modeled
closed state is shown in a ribbon
diagram in red.

the monomer, indicates our proposed dimer interface is influencing the global dynamics of SecA,
and providing flexibility to the PBD and HWD regions of the structure. These regions are distal
to the proposed dimer interface and the observation is consistent with an allosteric mechanism
where dimerization is linked to an open to closed transition.
For more details on this section, please see Biochemistry, 2014, 53(19), 3248-3260.

6.5 Discussion
In the research described in this chapter, we utilized HDX MS in combination with site-directed
mutagenesis/AUC performed by our collaborators, to probe the dimer interface of SecA in
solution. HDX examines the effects of dimerization based on changes in peptide backbone
solvent accessibility, with spatial resolution limited by digestion coverage and peptide size,
whereas site-directed mutagenesis/AUC measures the energetic contributions of individual
residues to dimerization. The HDX measurements were performed with a limited (10 s) time
resolution and are, thus, insensitive to faster processes.
The HDX MS and AUC data together indicate that the HSD is a component of the dimer
interface. Site-directed mutagenesis/AUC shows that residues Q662 and E665 lying at the Cterminus of the long transducer helix in the HSD are involved in dimerization. The HDX results
implicate a larger region within the HSD, including the entire transducer helix and the two-helix
finger. The difference in the extent of HSD involvement in the dimer interface detected by these
methods may arise because some of the interfacial residues do not provide a large energetic
contribution to dimerization. Alternatively, the transducer helix is known to be mobile(37), and
changes in the accessibility of this helix upon dimerization may be communicated to regions
lying distal from the dimer interface. With the exception of the E. coli structure (PDB 2FSF),
each of the SecA crystal structures includes N-terminal portions of the transducer helix within
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the dimer interface (Figure 6-2). However, only the B. subtilis 1M6N interface also encompasses
the C-terminal region of this helix identified by AUC.
The AUC data indicate that the N-terminus contributes to the SecA dimer interface whereas
HDX does not detect differences in this region between the monomer and dimer states. This
discrepancy is likely associated with the flexible nature of the N-terminus. In this region, the
deuterium uptake reaches a maximum at the shortest exchange time point (10 s), precluding
detection of an interface by HDX, consistent with high on and off rates for the interaction. Our
data demonstrating the involvement of the N-terminus in the SecA dimer interface disagrees with
three dimer structures (PDB: 2FSF, 1NL3, and 2IBM) that do not include the N-terminus as part
of the dimer interface. Note that these three structures were solved using SecA deletion mutants.
Specifically, the E. coli SecA (PDB 2FSF) structure was solved using an N-terminus deletion
mutant (Residues 9-861). In contrast, the dimer interfaces from T. thermophilus (PDB 2IPC) and
B. subtilis (PDB 1M6N) structures contain the N-terminus.
Overall, the HDX and AUC data appear most consistent with the B. subtilis SecA 1M6N
antiparallel dimer arrangement(27). However, only 5 out of 14 alanine substitutions predicted to
diminish dimerization affinity based on the 1M6N interface actually reduced dimerization of E.
coli SecA, despite the 50% sequence identity between these orthologs. This discrepancy may
indicate that the solution interface dimer is similar, but not identical, to that found in the 1M6N
structure and, thus, none of the crystal structures may correspond to the interface adopted by
cytoplasmic SecA. Also, another possible explanation is that different salt concentrations and
buffer conditions may lead to the formation of slight different dimer interfaces. Alternatively, it
was recently reported that SecA adopts multiple dimeric interfaces during translocation(51) and
these may exist in equilibrium in solution. Both proposed dimer interfaces, based on the 1M6N
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structure and an interface found in the M. tuberculosis 1NL3 crystal form (but different from the
one depicted in Figure 6-2E), include the N-terminal region and portions of the HSD and HWD.
However, the latter interface does not include residues Q662 and E665 that we found to affect
SecA dimerization or the N-terminal portions of the transducer helix that are protected from
HDX by dimerization. In agreement with our results, inter-protomer distances derived from
fluorescence resonance energy transfer measurements are also most consistent with the 1M6N
interface(34, 35).
The HDX data also reveal that dimerization induces movement of the PBD into a closed
conformation where it interacts with the HWD. Normal mode analysis supports such an allosteric
mechanism where dimerization is linked to an open to closed transition. We identified a low
frequency mode in the dimer but not in the monomer that is coupled to the PBD-HWD
separation. Consistent with correlation of SecA dimerization with a closing transition of the
PBD, B. subtilis SecA adopts an open conformation in a monomeric crystal form (1TF5)(38)
whereas closed forms are found in two dimeric crystal forms of the same enzyme(27, 30). Cryoelectron microscopy analysis of dimeric E. coli SecA reveals a closed state(14). However, this
correlation is not always observed, as a monomeric complex of T. maritima SecA with ADP can
be crystalized in a closed state(37) and a crystal structure of dimeric E. coli SecA (PDB 2FSF)
reveals an open state(31). Crystal packing forces may influence the conformation of the PBD.
Consistent with a low barrier for this transition, solution NMR suggests that dimeric SecA
rapidly interconverts between a closed state and a predominant open state(8). FRET
measurements indicate that signal peptide binding induces dimeric SecA to adopt a more open
conformation(35). Binding of a non-signal sequence peptide in the groove between PBD and NBD
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II results in rotation of the PBD towards NBD II(37) and interaction of SecA with SecYEG
induces further movement of the PBD to close the clamp(24).
Our analysis can be interpreted in the context of the closed state model of the E. coli SecA dimer
based on the 1M6N structure (Figure 6-5C). The dimer interface is primarily contributed by the
HSD and the N-terminus, two regions that lie on the same side of the protomer. The C-terminal
domain regions that form an interface with the PBD become less dynamic upon dimerization
(Figure 6-5D). However, the corresponding colored regions in the PBD are not in close contact
with the C-terminal domain. Most of the colored residues in the PBD are also removed from the
inter-protomer interface, but a short loop does contribute to dimerization (residues 338-342) and
a portion of the reduced HDX in the PBD may be directly associated with dimerization. The two
regions in the PBD making close contact with the C-terminal domain, residues 263-268 (loop)
and 304-314 (α helix), do not show significant ΔD% between monomer and dimer. Region 263268 is a flexible loop that reaches 60% deuterium exchange at the shortest HDX time point, 10 s,
and 80% at 4 h. In contrast, the helix in region 306-314 is rigid and shows less than 5%
deuterium exchange at the longest HDX time point, 4 h. Thus, the absence of a detectable
difference in monomer and dimer HDX for these regions can be ascribed to very fast and very
slow exchange, respectively, that lie outside the time resolution of the present study.
Several studies show that SecA is dimeric when driving preprotein translocation across
SecYEG(15, 19, 20, 37, 52, 53) whereas others report that the functional form of SecA is monomeric(18,
24, 25)

. Regions within the PBD and C-domain of SecA interact with the C-terminal region of

SecY(24). When SecA binds to SecYEG, the PBD moves away from HWD and closer to the NBD
II(24). The B. subtilis (PDB 1M6N) dimer interface supported by the data presented here does not
overlap with the SecA-SecYEG interface so that the intact dimer could interact with SecYEG.
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Interaction with SecYEG and subsequent ATP hydrolysis may induce SecA dimer dissociation
during the translocation cycle(1,

51)

. In this context, the movement of the PBD to an open

conformation upon SecA dimer dissociation may facilitate transfer of the preprotein to the SecY
pore.
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Chapter 7*
Fast Photochemical Oxidation of Proteins (FPOP) Maps the
Epitope of EGFR Binding to Adnectin

*
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7.1 Abstract
Epitope mapping is an important tool for the development of monoclonal antibodies, mAbs, as
therapeutic drugs. Recently, a class of therapeutic mAb alternatives, adnectins, has been
developed as targeted biologics. They are derived from the tenth type III domain of human
fibronectin (10Fn3). A common approach to map the epitope binding of these therapeutic proteins
to their binding partners is X-ray crystallography. Although the crystal structure is known for
Adnectin 1 binding to human EGFR, we seek to determine complementary binding in solution
and to test the efficacy of footprinting for this purpose. As a relatively new tool in structural
biology and complementary to X-ray crystallography, protein footprinting coupled with mass
spectrometry is promising for protein-protein interaction studies. We report in this chapter the
use of fast photochemical oxidation of proteins (FPOP) coupled with MS to map the epitope of
EGFR-Addnectin 1 at both the peptide and amino-acid residue levels. The data correlate well
with the previously determined epitope from the crystal structure and are consistent with HDX
MS data. The FPOP-determined binding interface involves various amino-acid and peptide
regions near the N terminus of EGFR. The outcome adds credibility to oxidative labeling by
FPOP for epitope mapping and motivates more applications in the therapeutic protein area as a
stand-alone method or in conjunction with X-ray crystallography, NMR, site-directed
mutagenesis, and other orthogonal methods.
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7.2 Introduction
Epitope mapping is an important step in the characterization of monoclonal antibodies (mAb) for
their use as therapeutic drugs. Therapeutic applications of mAbs are emerging or under
development for oncology, autoimmune diseases, inflammatory disorders, and organ
transplantation. Recently, a new class of biologics that mimic the binding region of mAbs,
Adnectins, has been developed as therapeutic mAbs analogs(1-3).
Adnectins are a class of biologics developed from the tenth human fibronectin type III domain
(10Fn3), and they bind target proteins as potential therapeutic agents(1-6).

10

Fn3 is a small (10

kDa), highly stable and soluble β-sandwich protein that resembles an immunoglobulin variable
domain but has no disulfide bonds(7-10). The protein fold contains three solvent-exposed loops,
termed BC, DE and FG, which are structurally analogous to antibody complementaritydetermining regions (CDRs) and tolerant to extensive mutations(4). Mutations in the loops can
impart different binding capacities to the

10

Fn3-based variants. Therefore, adnectins can have

similar functions as therapeutic monoclonal antibodies by binding with high affinity to their
targets. The first adnectin tested in preclinical and phase I studies, CT-322, targets vascular
endothelial growth factor receptor-2, giving some desired pharmacological effects(11-14).
Epidermal growth factor receptor (EGFR), a member of the ErbB receptor family, mediates cell
proliferation, differentiation, survival, angiogenesis, and migration(15).

EGFR

has been

implicated in many human cancers(16). Its structure consists of an extracellular domain
(exEGFR), a transmembrane domain, and an intracellular tyrosine-kinase domain. Cell signaling
is initiated by binding of ligands, such as EGF, to exEGFR, followed by dimerization of EGFR
and phosphorylation of specific EGFR tyrosine residues(15). We recently studied the effects of
dimerization and subsequent phosphorylation by mass spectrometry (MS)-based footprinting of
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one family member attached to a membrane(17). Tyrosine-phosphorylated receptors serve as
docking sites for intracellular signaling proteins, which initiate many signaling cascades to
produce a physiological outcome(18). This EGFR signaling network is often dys-regulated in
cancer and motivates a strategy for cancer therapy with EGFR-blocking agents, including mAbs
targeting exEGFR and small molecules targeting the EGFR intracellular domain(19-21).
To develop mAb alternatives for cancer therapy, a representative adnectin (Adnectin 1) that
specifically binds EGFR was generated using the mRNA display technique(22,

23)

. As a

requirement in therapeutic drug development, the EGFR-Adnectin 1 interaction was previously
characterized, in this case by X-ray crystallography, revealing the binding epitope to be distinct
from those of approved mAbs(22). Although X-ray crystallography is often regarded as the “gold
standard” for structure determination, it has limitations. For example, crystallization is
sometimes difficult for certain antigen-antibody complexes and requires a relatively large
amount of protein. Furthermore, whether contacts from crystal structures faithfully represents
biologically relevant protein-protein interfaces is questionable(24,

25)

. Another approach, site-

directed mutagenesis(26), is labor intensive and could cause false positives because the protein is
submitted to modifications, some of which could affect structure.

Binding assays(27) and

PEPSCAN(28) are often restricted to linear (continuous) epitopes, and are likely to fail when
facing conformational (discontinuous) epitopes, characterization of which requires maintaining
the native structure of both antigen and antibody. Limited proteolysis(29) followed by MS
analysis is another approach but of low resolution.
There is a growing interest in mass-spectrometry-based methods for mapping epitopes and other
protein-ligand interactions.

Two appropriate approaches are hydrogen-deuterium exchange

(HDX)(30-36) and oxidative labeling (e.g., OH radicals, FPOP)(37-40). These methods are sensitive,
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can accommodate large proteins, and can be used with the protein in native or near-native states.
For example, the epitope of EGFR binding to Adnectin 1 was mapped by Iacob and Engen using
HDX MS(41), and the results correlate well with the structure from X-ray crystallography.
Oxidative labeling has advantages because the labeling is fast, irreversible, and residue-level
information can often be generated. Fast oxidative labeling (millisec time scale) was first
established by Chance and coworkers(42) by radiolytic modification. Photochemical labeling
initiated by laser irradiation of H2O2 was later developed by different groups(43-45). Of those
methods, photochemical oxidation of proteins (FPOP), developed by Hambly and Gross(45), uses
a flow system and controls the radical life to ~ 1 µs by introducing a radical scavenger to prevent
excessive labeling. Recently, Jones and Gross(40) reported the use of FPOP coupled to MS to
map the conformational epitope of the serine protease thrombin and showed results that are
consistent with those from HDX.
In this chapter, we describe the use of FPOP to map the epitope of exEGFR-Adnectin 1 complex.
To accomplish the mapping, we modified the experimental conditions from traditional FPOP
settings to allow measurement in formulation-relevant conditions and to produce moderate
amount of oxidation of exEGFR even in the presence of the adnectin. The FPOP data are largely
consistent with the X-ray crystallography results, which show that the epitope binds at the N
terminus in Domain I, as shown by decreased modifications upon Adnectin 1 binding. In
addition, FPOP also revealed changes of a residue located outside the previously determined
binding interface, F24, which may be due to an allosteric change in side-chain orientation that
produces decreased solvent accessibility.
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7.3 Experimental
7.3.1 Materials and Reagents
30% hydrogen peroxide, formic acid, trifluoroacetic acid, L-histidine, L-glutamin, L-methionine,
catalase, phosphate-buffered saline, ammonium bicarbonate, dithiothreitol (DTT), iodoacetamide (IAA), and HPLC-grade solvents were purchased from Sigma Aldrich (St. Louis,
MO). Trypsin/Lys-C Mix was obtained from Promega Corp. (Madison, WI). PNGase F was
purchased from New England Biolabs inc (Ipswich, MA). RapiGest SF was from Waters Corp.
(Milford, MA). West Nile Virus E protein Domain III (WNV E DIII) was provided by D.
Fremont from Department of Pathology and Immunology at Washington University, school of
medicine. Human exEGFR (residues 1-642) was expressed in Sf9 cells mammalian cells with a
C-terminal His tag and purified as described previously(22). It was supplied in phosphate buffer
saline (PBS:137mM NaCl, 2.7mM KCl, 10 mM Na2HPO4, 2 mM KH2PO4 (pH 7.2). Adnectin 1
was supplied in PBS buffer (pH 7.2). Its expression and purification were described
previously(22).

7.3.2 FPOP labeling of Proteins
exEGFR and Adnectin 1 were mixed together at a 1:1 molar ratio at 50 µM concentration (Kd ~ 2
nM(22)) and incubated for 1 h at room temperature. FPOP labeling of proteins was performed on
the same day under the same conditions. Each sample started with 5 µM protein reconstituted in
1×PBS containing 350 µM His and 20 mM H2O2. H2O2 was added just prior to infusing the
solution into the tubing for FPOP. FPOP was performed as described previously(45, 46). The KrF
excimer laser power (GAM Laser Inc., Orlando, FL) was adjusted to 44 mJ/pulse, and its pulse
frequency set to 6.5 Hz. The width of the laser beam at the clear sample tube window was 1.8
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mm. The flow rate was adjusted to 15 µL/min to ensure a 20% exclusion volume to avoid
repeated HO‧exposure and reaction(44). All collections were in vials containing 10 mM catalase
and 20 mM Met to reduce left-over H2O2. For each state, exEGFR with Adnectin 1 and exEGFR
alone, three separate samples were made and submitted to FPOP labeling. In addition, three
control samples for exEGFR alone were handled in the same manner, but they were not laser
irradiated. All samples were stored at -80 °C after solvent evaporation if they were not directly
subjected to trypsin digestion.

7.3.3 Proteolysis
A 20 µL aliquot of each FPOP-labeled exEGFR sample was mixed with 2 µL of RapiGest SF
and incubated at 80 °C for 15 min. The samples were reduced with 10 mM dithiothreitol (2 µL of
10 mM solution) at 55 °C for 30 min, alkylated with 23 mM iodoacetamide (2 µL of 300 mM
solution) in the dark at RT for 30 min, and deglycosylated with 2 µL PNGsae F at 37 °C for 2 h.
Solutions of 40 µL of 1×PBS and 24 µL of 0.1 M ammonium bicarbonate were then added to
each aliquot to bring the pH to ~8. Samples were digested overnight with the Trypsin/Lys-C Mix
at an enzyme:protein ratio of 1:25. The reaction was quenched with trifluoroacetic acid (TFA) to
give a final concentration of 1%. An aliquot of 30 µL of the digested samples was cleaned up
with NuTip C-18 zip tips (Glygen Corp., Columbia, MD) and eluted into 30 µL of 60%
acetonitrile/40% H2O/0.1% formic acid (FA). The eluent was dried and reconstituted in 30 µL
of water with 0.1% FA for autosampler loading and subsequent analysis.

7.3.4 Mass Spectrometry
For peptide and residue level analysis of labeled exEGFR, samples were analyzed on a LTQ
Orbitrap XL (Thermo Fisher, San Jose, CA) operated in data-dependent acquisition mode. An
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aliquot of 5 µL of each sample was loaded by the autosampler onto and eluted from a 15 cm
column with a PicoFrit tip (New Objective, Inc., Woburn, MA), custom-packed with C18
reversed phase material (Magic, 0.075 mm × 150 mm, 5 µm, 100 Å; Michrom Bioresources Inc.,
Auburn, CA); the chromatograph was an Ultra 1D+ UPLC (Eksigent, Dublin, CA). Peptides
were eluted by a 95 min, 260 nL/min gradient coupled to the nanospray source. The gradient
started with a linear increase from 2% of solvent B (CH3CN/0.1%FA) to 32% in 65 min, and
then to 90% in 13 min, held at 90% B for 5 min, and re-equilibrated to solvent A (H2O/0.1%FA)
for 12 min. Mass spectra were obtained at high mass resolving power (60,000, FWHH, for ions
of m/z 400), and the six most abundant ions eluting per scan were subjected to CID MS2 in the
ion trap, with charge-state rejection of +1 ions enabled. Precursor ions were added to a dynamic
exclusion list for 12 s to ensure good sampling of each elution peak.

7.3.5 Adjustment of the Scavenger for FPOP
FPOP used an excimer laser to photolyze hydrogen peroxide to give two OH radicals; the H2O2
was added in low concentration to the protein solution, to form hydroxyl radicals(45,

47)

. To

control the radical lifetime, a pulsed laser and selected scavenger of 20 mM Gln were used for
protein labeling at a microsecond time scale, faster than protein unfolding(46). There were
concerns, however, regarding the impact of high concentration of Gln on protein conformation
and behavior and whether it faithfully mimicked the protein native state.
Thus, His, a common reagent in protein formulation buffers, was selected to replace Gln as a
scavenger in the FPOP experiments. Because the reaction rate constant of ‧OH with His is larger
than that with Gln, His was expected to be a more efficient scavenger than Gln and to work at
lower concentrations. To determine the concentration of His as an alternative to the previously
used 20 mM Gln scavenger, each sample started with 10 µM WNV E DIII (a model protein), 20
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mM H2O2 and different concentrations of His (200 µM, 350 µM, 500 µM) or 20 mM Gln in
1×PBS. The traditional FPOP condition with 20 mM Gln was included to serve as a positive
control. After FPOP labeling, protein-level analysis of labeled WNV E DIII was performed on a
Bruker Maxis 4G MS (Bruker Biosciences Corporation, Billerica, MA). Samples were trapped
on a 2×15 mm C8 trap column (Agilent, Santa Clara, CA, USA) and desalted with a 3 min flow.
A 5 min linear gradient of 4-40% CH3CN in 0.1% formic acid was used to elute the sample for
protein-level analysis. The peak corresponding to +8 charge state from the global mass spectrum
was used for data analysis
Global analysis with the custom program afforded the fraction of unmodified protein after FPOP
for all four conditions, as shown in Table 7-1. The table indicates that 350 µM His gave the
closest scavenging ability comparing to 20 mM Gln. According to previous studies(48), one
important criterion indicating the sampling of a single (native) conformation of the protein is the
Poisson distribution of +0, +16, +32 species after FPOP labeling. Therefore, a more rigorous
analysis was conducted, to model the product distribution for all four experiments. The goodness
of the fit was indicated by the “Poisson distribution factor” in Table 7-1, for which a value closer
to “1” indicated the better fit. The result also indicated the suitability of 350 µM His as a
scavenger for FPOP experiments.
Table 7- 1. Analysis of FPOP modification on WNV E DIII at protein level with
different scavengers
Scavenger

Unmodified WNV E DIII%

Poisson distribution factor

20 mM Gln

24.9%

0.89

500 µM His

26.4%

0.89

350 µM His

26.2%

0.91

200 µM His

17.4%

0.75
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7.3.6 Data Analysis for FPOP labeling of exEGFR
The raw MS files were converted to .mgf files and profile mzXML files by using MassMatrix
Mass Spec Data File Converter. The .mgf files of control samples were searched using
MASCOT (Matrix Science, London, U.K.) against a custom-built database containing the
sequence of exEGFR for sequence coverage and including deamidation at Asn or Gln, which
results from N-deglycosylation in the sample handling. Oxidation at Met was also added as a
variable modification. The alkylation of the samples with iodo-acetamide added a
carbamidomethyl group (MW= 57.0214) to cysteines; therefore, it too was set as a fixed
modification in the search. Several Asn residues were found to be entirely deamidated to form
Asp or isoAsp, and they were changed in the sequence from N to D for further FPOP
modification analysis. The profile mzXML files of all samples were then searched against the
modified sequence for labeled and unlabeled exEGFR tryptic peptides by using ProtmapMS 2.1
(Case Western Reserve Univ., OH) with oxidative mode set to 2, meaning up to two variable
modifications were allowed to occur on the same peptide. All known hydroxyl radical side-chain
reaction products(49-51) were added to the modification database for searching as variable
modifications. Carbamidomethyl group modification on Cys was added as a fixed modification.
From the identified modifications on each tryptic peptide (Table 7-2), the intensities of signals
for the modified (Iox) and the unmodified species (I) for each peptide were then read from the
raw data files. The extents of modification at peptide level were calculated by using the
following equation(52):

∑
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∑

!

!

+

Table 7- 2. Modifications by FPOP on all peptides as identified by ProtmapMS
peptide

Modification species
15.995 13.979 -10.032 -22.032 31.99
-30.011 4.979
-22.032 -31.99
14-29
+
+
30-48
+
49-56
+
57-74
+
75-84
+
85-105 +
106110115+
+
+
126+
+
142+
+
166+
189+
201+
203+
+
+
221+
230+
+
238+
+
261+
+
+
261+
274+
+
+
+
+
286+
286+
+
+
+
311+
312+
323+
+
334337+
+
354+
+
+
+
+
376+
+
391+
+
+
408+
+
428+
431+
+
444+
+
444+
+
456+
+
477+
+
+
+
515+
524+
+
+
“+” indicates the modification is detected and “-” indicates the modification is not detected
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Quantitative analysis of oxidative labeling at residue level was also performed for regions that
showed differences in extent of modification at the peptide level between exEGFR alone and
exEGFR with Adnectin 1. Modification sites on the peptide were assigned with MS2
information. In a few cases, where location of a modification to a single residue wasn’t possible
owing to limited fragmentation information from MS2 or to the presence of interference from coelution of peptide isomers, the modification was indicated to occur on a set of possible residues.

7.4 Results and Discussion
7.4.1 FPOP labeling and analysis of exEGFR
FPOP is a chemical footprinting approach that uses short-lived ‧OH radicals to “snapshot” the
state of a protein or a protein-complex. Hydroxyl radicals probe the solvent accessibility of the
protein because its size is similar to that of water molecules, and its high reactivity allows
modification of up to 14 of 20 amino acids. In the presence of a scavenger, the radical lifetime is
controlled to the µs timescale, which allows fast labeling presumably of a single state of the
protein. In most FPOP footprinting experiments, the comparison is two-state; that is, of the same
site of a protein existing in two states to reveal changes in solvent accessibility.
By introducing an irreversible modification, the FPOP-introduced label is maintained during
post-labeling sample handling, making it adaptable to a typical “bottom-up” proteomics
methodology of proteolysis and LC/MS/MS. This robustness is important for membrane and
secreted proteins containing complex glycosylation and other modifications, which are important
for the structural and functional roles of the protein(53). The diversity of glycan modifications
often adds to the difficulty of data processing in proteomics studies. In the case of exEGFR, we
found that, without a deglycosylation step, trypsin digestion followed by typical database
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searching gave only 74% of sequence coverage. Missing were several regions between AA320 to
AA550. Interestingly, these missing regions all contain a “NXT” sequence, which is the common
site for N-glycosylation. Therefore, we added a deglycosylation step before trypsin digestion to
bring the coverage up to 89%, yet still missing several short regions containing multiple Lys or
Arg residues (Figure 7-1).

Figure 7- 1. Coverage map obtained for the tryptic digest of exEGFR.

7.4.2 Epitope mapping of exEGFR-Adnectin 1
We first performed FPOP labeling of exEGFR with 350 µM His as scavenger in the absence of
Adnectin 1 and analyzed the oxidation extent at the peptide level to evaluate the labeling
efficiency. This is important because different proteins contain different reactive sites, and,
therefore, may require different concentrations of scavengers to achieve a proper modification
extent. Because exEGFR is much larger in size than WNV E DIII, it is unlikely to get over149

oxidized but possibly under-oxidized under the same scavenger concentration. Therefore, we
only studied the oxidation extent but didn’t perform distribution analysis for the peptides after
FPOP labeling. The results showed that moderate oxidation, between 0% and 25%, can be
achieved for all peptides (darker bars in Figure 7-2). This outcome is the basis for a more
detailed FPOP study of the two states.

Figure 7- 2. Extent of modification of EGFR alone (dark bars) and Adnectin 1-bound EGFR
(light bars) for tryptic peptides covering 89% of the sequence. The light bar in 57-74 is absent
because the modification extent is less than 0.1%, and so are several other peptides.
When comparing the modification extent of the two states of exEGFR, we used the Student’s t
test on the sets of triplicates of both states for each peptide to determine if the two sets of data are
significantly different from each other. The two-sample, two-tailed t test was applied assuming
unequal variances, and the resulting P values for each peptide are listed in Table 7-3. We found a
decrease in modification extent at the N-terminus for 2 of the 42 tryptic peptides of exEGFR
upon Adnectin 1 binding, namely, for peptides 14-29 and 57-74 (“**” in Figure 7-2), of which
the P values are 0.006 and 0.007, respectively. On the contrary, most of the other peptides have
larger P values (Table 7-3), indicating no significant difference in oxidation extent between the
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free and bound states of exEGFR. Three
other peptides, namely, 75-84, 115-125

Table 7- 3. Student’s t-tests for all triplicates
of both EGFR free and EGFR-Adnectin1
bound states.

and 323-333, also have relatively small P

peptide

P value

Peptide

P value

values (0.03 < P < 0.05) compared to

14-29
30-48
49-56
57-74
75-84
85-105
106-114
110-114
115-125
126-141
142-165
166-185
189-198
201-220
203-220
221-228
230-260
238-260
261-269
261-270
274-285

0.006
0.822
0.421
0.007
0.044
0.449
NA
NA
0.032
0.123
0.807
0.617
0.713
0.087
0.147
0.598
0.253
0.453
0.446
0.902
0.425

286-300
286-301
311-322
312-322
323-333
334-353
337-353
354-372
376-390
391-403
408-427
428-443
431-443
444-454
456-463
477-497
515-523
524-550
551-569
570-585
586-618

0.641
0.157
0.143
0.177
0.048
NA
0.069
0.352
0.517
0.122
0.063
0.186
0.686
0.052
0.403
0.231
0.104
0.541
0.111
0.635
0.570

most of the data (“*” in Figure 7-2),
showing a similar trend of increased
protection in the bound state. These
differences are too small, however, and
might be caused by structure fluctuations
upon Adnectin binding rather than by
interactions at the direct binding site.
Noteworthy is that the modification
extents for both states presented here are
already

adjusted

by

deducting

the

modification percentage in the control
samples from them, in an effort to exclude oxidation introduced during sample handling. The
reduced reactivity at those two regions indicates reduced solvent accessibility upon binding,
suggesting that they are at or near the location of the binding site with Adnectin 1, assuming no
allosteric effects are occurring.
To obtain residue-specific information of the binding site, we performed residue-level analysis
on the two regions that showed different modification extents for the two states. For example, the
extracted ion chromatograms (EIC) and the corresponding mass spectra of peptide 14-29
(unmodified and +16 modified) are shown in Figure 7-3a and Figure 7-3b, respectively,
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indicating a mass shift of 15.9936 Da after modification. To assign residue-specific information
to peptides eluting at each peak in the EIC, a single MS/MS scan of the +16 species at one
elution time is used. An example product-ion spectrum of peptide 14-29 with a +16 modification
from a single sampling (peak 1 in Figure 7-3a) is shown in Figure 7-4a. Two product ions at m/z
725.5 and 790.0, assigned to y12 and y13 +16, respectively, indicated the +16 modification is on
L17. This assignment is also supported by other fragment ions, such as b3 and b4 +16. Similarly,
Figure 7-4b shows an isomeric peptide with a +16 modification eluting at a different time (peak
2 in Figure 7-3a) and demonstrating that another oxidative modification occurs at a different
location, here shown to be F20. In some cases, the product-ion spectrum was insufficiently
informative for the assignment of the modification to a single residue.

In that case, the

modification was assigned to the narrowest region determined by fragment ions (e.g., region
L17-H23). Worth mentioning is that positional isomers of the same residue modification are also
separated in the EIC, and such peaks corresponding to the same site modification are added
together for calculation.
a 100

b 100
SIC of unmodified peptide 14-29

60

60

40

40

20
0
100

SIC of modified (+16) peptide 14-29

80

MS of unmodified peptide 14-29

80

Relative Abundance

Relative Abundance

80

636.0039
635.6703

60

636.3378

636.6719
20
637.0063
0
100
80

641.0015 641.3358

MS of modified (+16) peptide 14-29

60

40

641.6701

40
1

20

2

642.0045

20

642.3383
0

0
52

55

58

61

Time (min)

636

638

640

642

m/z

Figure 7- 3. (a) Extracted ion chromatograms of peptide 14-29 unmodified (top) and +16
modified (bottom). (b) Mass spectra of peptide 14-29 normalized to 100% unmodified (top) and
modified (bottom).
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40
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343.1
0

200

400
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600
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800

y15+O
904.5
1000

Figure 7- 4. Product-ion (MS/MS) spectrum of peptide 14-29 with +16 modification on (a) L17,
colored in red and (b) F20, colored in red.
A total of seven specific residues or short regions were identified to bear the oxidations in the
regions represented by peptides 14-29 and 57-74; all but one showed protection upon Adnectin 1
binding (Figure 7-5). A similar Student’s t-test also performed on the seven residues evaluated
the significance of the observed differences between the two states (Table 7-4). For peptide 1429, residues L14, L17, F20, F24 were modified and showed different modification extents
between the bound and unbound states (P ≤ 0.02), whereas another modification assigned to
region L17-H23 showed no change between the two states (P = 0.2). In addition to the Nterminal residues, L69 from peptide 57-74, assigned with MS/MS, was also found to undergo
decreased solvent accessibility and labeling extent upon Adnectin 1 binding (P = 0.03). There is
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another +16 modification of peptide 57-74, but we were unable to determine its location from the
MS/MS information.
0.14

Extent of Modification

0.12

0.1

0.08

0.06

0.04

0.02

0
L14

L17

F20

F24

L17-H23

57-74unknown

L69

Figure 7- 5. Extent of modification of EGFR alone (dark bars) compared to Adnectin 1-bound
EGFR (light bars) at the residue level for regions that showed labeling differences between the
two states at peptide level.
Table 7- 4. Student’s t-tests for all seven residues or short regions labeled in peptide
14-29 and 57-74 of both EGFR free and EGFR-Adnectin1 bound states.
residue
L14
L17
F20
F24
L17-H23 57-74unknown
L69
p value 0.003
0.017
0.014
0.021
0.204
0.03
0.032

7.4.3 Epitope detected by FPOP labeling vs. by other methods
To compare the epitope of EGFR bound to Adnectin 1 as determined by FPOP labeling and
crystallography, we mapped the five residues identified to undergo decreased labeling upon
Adnectin 1 binding on the crystal structure of exEGFR-Adnectin 1 (PDB: 3QWQ, Figure 7-6).
Four of the five residues, L14, L17, F20 and L69, lie at the interface of the two species when
mapped onto the exEGFR-Adnectin 1 crystal structure (Figure 7-6). Specifically, the differential
modification of L17 from FPOP labeling is consistent with the crystallography study(22), which
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shows that L17 interacts with K79 of Adnectin 1 via H-bonding. The crystallography also
pinpoints several neighboring residues (T15, Q16 and G18) that interact with Adnectin 1 via Hbonding, and others (L14, L69, S99 and Y101) that interact via van der Waals forces.
Information on T15, Q16 and G18 was not obtained, however, by FPOP labeling owing to a lack
of reactivity of these residues. Although FPOP resolved interactions involving L14 and L69, it
was silent concerning S99 and Y101 because these residues showed little reactivity; evidence for
oxidation on those two residues was unclear because of interference from the highly oxidized
M87 (located in an exposed loop) on the same peptide in the LC chromatogram. F20, although
not thought to interact with ligands of EGFR, is at the buried surface of Adnectin 1 binding
determined by crystallography, and, therefore, shows decreased solvent accessibility in the
complex. The last residue, F24, changing its solvent accessibility as identified by FPOP,
however, is distant to the putative EGFRAdnectin 1 interface according to the
crystal structure. The decrease in labeling
extent on F24 may be due to a change of
side-chain

orientation

that

leads

to

decreased solvent accessibility or a slight
change in solvent accessibly (from small
to smaller) allosterically controlled by
Adnectin binding.
When comparing the epitope mapped by
HDX(41) and by FPOP labeling, we also
found

good

consistency.

HDX

MS

Figure 7- 6. Structural model of EGFR-Adnectin
1 (PDB file 3QWQ) with the interacting residues
from Adnectin 1 colored in magenta, and domain
I of exEGFR, in other colors. Residues from
regions 14-29 and 57-74 that showed different
modification extents are in green.
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coupled with ETD achieved epitope mapping at residue level and the most important interaction
site was assigned as K13 to Q16. Noteworthy is that, unlike HDX, FPOP labeling is a measure of
solvent accessibility of a side chain whereas HDX responds to changes in H-bonding of the
protein backbone. Therefore, the two methods provide orthogonal information in epitope
mapping, and both can complement other epitope mapping methods, such as X-ray
crystallography, but reveal more relevant solution binding.

7.5 Conclusions
As a relatively new protein footprinting method, FPOP is less studied than HDX in applications
involving mapping epitopes of protein antigens. In this application, we make two-state (bound
and unbound) comparisons of labeling extents at identical sites.

The comparisons reflect

changes in solvent accessibility accompanying intermolecular interactions or allosteric
changes(48). The irreversible nature of FPOP labeling allows for complicated sample handling
before MS detection, including deglycosylation, digestion, and long chromatography. This
attribute is particularly important when dealing with complex samples and achieving good
coverage and detailed CID analysis for residue-specific information. Here, we demonstrated the
successful application of FPOP in mapping the epitope of EGFR-Adnectin 1 complex, showing
largely consistent results with that from X-ray crystallography and HDX studies but revealing an
additional interaction site. Five residues or short regions show decreased modification extent
upon Adnectin 1 binding; of these, four lie in the binding interface determined by the crystal
structure. The other (F24) is possibly caused by a change in side-chain orientation or a decrease
in solvent accessibility of Adnectin 1 when bound. One advantage of MS-based protein
footprinting is that it can sample physiologic mixtures. Therefore, FPOP and/or HDX can be
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used as stand-alone methods or in conjunction with crystallography to elucidate confidently
specific binding sites of antigens in a physiological-relevant solution state.

7.6 Acknowledgements
This research was supported by the NIH, NIGMS P41 grant (P41GM103422) to MLG. The
authors thank Dr. Reb Russell, Dr. Sharon Cload and Dr. Bruce Car from Bristol-Myers Squibb
for their support of this project.

157

7.7 References
1.

Xu, L., Aha, P., Gu, K., Kuimelis, R. G., Kurz, M., Lam, T., Lim, A. C., Liu, H., Lohse,
P. A., Sun, L., Weng, S., Wagner, R. W., and Lipovsek, D. (2002) Directed evolution of
high-affinity antibody mimics using mRNA display, Chemistry & biology 9, 933-942.

2.

Hackel, B. J., Kapila, A., and Wittrup, K. D. (2008) Picomolar affinity fibronectin
domains engineered utilizing loop length diversity, recursive mutagenesis, and loop
shuffling, Journal of molecular biology 381, 1238-1252.

3.

Wojcik, J., Hantschel, O., Grebien, F., Kaupe, I., Bennett, K. L., Barkinge, J., Jones, R.
B., Koide, A., Superti-Furga, G., and Koide, S. (2010) A potent and highly specific FN3
monobody inhibitor of the Abl SH2 domain, Nature structural & molecular biology 17,
519-527.

4.

Koide, A., Bailey, C. W., Huang, X., and Koide, S. (1998) The fibronectin type III
domain as a scaffold for novel binding proteins, Journal of molecular biology 284, 11411151.

5.

Koide, A., Abbatiello, S., Rothgery, L., and Koide, S. (2002) Probing protein
conformational changes in living cells by using designer binding proteins: application to
the estrogen receptor, Proceedings of the National Academy of Sciences of the United
States of America 99, 1253-1258.

6.

Karatan, E., Merguerian, M., Han, Z., Scholle, M. D., Koide, S., and Kay, B. K. (2004)
Molecular recognition properties of FN3 monobodies that bind the Src SH3 domain,
Chemistry & biology 11, 835-844.

158

7.

Main, A. L., Harvey, T. S., Baron, M., Boyd, J., and Campbell, I. D. (1992) The threedimensional structure of the tenth type III module of fibronectin: an insight into RGDmediated interactions, Cell 71, 671-678.

8.

Dickinson, C. D., Veerapandian, B., Dai, X. P., Hamlin, R. C., Xuong, N. H., Ruoslahti,
E., and Ely, K. R. (1994) Crystal structure of the tenth type III cell adhesion module of
human fibronectin, Journal of molecular biology 236, 1079-1092.

9.

Leahy, D. J., Erickson, H. P., Aukhil, I., Joshi, P., and Hendrickson, W. A. (1994)
Crystallization of a fragment of human fibronectin: introduction of methionine by sitedirected mutagenesis to allow phasing via selenomethionine, Proteins 19, 48-54.

10.

Leahy, D. J., Aukhil, I., and Erickson, H. P. (1996) 2.0 angstrom crystal structure of a
four-domain segment of human fibronectin encompassing the RGD loop and synergy
region, Cell 84, 155-164.

11.

Mamluk, R., Carvajal, I. M., Morse, B. A., Wong, H., Abramowitz, J., Aslanian, S., Lim,
A. C., Gokemeijer, J., Storek, M. J., Lee, J., Gosselin, M., Wright, M. C., Camphausen,
R. T., Wang, J., Chen, Y., Miller, K., Sanders, K., Short, S., Sperinde, J., Prasad, G.,
Williams, S., Kerbel, R., Ebos, J., Mutsaers, A., Mendlein, J. D., Harris, A. S., and
Furfine, E. S. (2010) Anti-tumor effect of CT-322 as an adnectin inhibitor of vascular
endothelial growth factor receptor-2, mAbs 2, 199-208.

12.

Bloom, L., and Calabro, V. (2009) FN3: a new protein scaffold reaches the clinic, Drug
discovery today 14, 949-955.

13.

Molckovsky, A., and Siu, L. L. (2008) First-in-class, first-in-human phase I results of
targeted agents: highlights of the 2008 American society of clinical oncology meeting,
Journal of hematology & oncology 1, 20.
159

14.

Tolcher, A. W., Sweeney, C. J., Papadopoulos, K., Patnaik, A., Chiorean, E. G., Mita, A.
C., Sankhala, K., Furfine, E., Gokemeijer, J., Iacono, L., Eaton, C., Silver, B. A., and
Mita, M. (2011) Phase I and pharmacokinetic study of CT-322 (BMS-844203), a targeted
Adnectin inhibitor of VEGFR-2 based on a domain of human fibronectin, Clinical cancer
research : an official journal of the American Association for Cancer Research 17, 363371.

15.

Janmaat, M. L., and Giaccone, G. (2003) The epidermal growth factor receptor pathway
and its inhibition as anticancer therapy, Drugs of today 39 Suppl C, 61-80.

16.

Yarden, Y., and Sliwkowski, M. X. (2001) Untangling the ErbB signalling network,
Nature reviews. Molecular cell biology 2, 127-137.

17.

Zhang, H., Shen, W., Rempel, D., Monsey, J., Vidavsky, I., Gross, M. L., and Bose, R.
(2011) Carboxyl-group footprinting maps the dimerization interface and phosphorylationinduced conformational changes of a membrane-associated tyrosine kinase, Mol Cell
Proteomics 10, M110 005678.

18.

Schlessinger, J. (2000) Cell signaling by receptor tyrosine kinases, Cell 103, 211-225.

19.

Masui, H., Kawamoto, T., Sato, J. D., Wolf, B., Sato, G., and Mendelsohn, J. (1984)
Growth inhibition of human tumor cells in athymic mice by anti-epidermal growth factor
receptor monoclonal antibodies, Cancer research 44, 1002-1007.

20.

Sato, J. D., Kawamoto, T., Le, A. D., Mendelsohn, J., Polikoff, J., and Sato, G. H. (1983)
Biological effects in vitro of monoclonal antibodies to human epidermal growth factor
receptors, Molecular biology & medicine 1, 511-529.

21.

Flynn, J. F., Wong, C., and Wu, J. M. (2009) Anti-EGFR therapy: mechanism and
advances in clinical efficacy in breast cancer., J. Oncol. 10.1155/2009/526963.
160

22.

Ramamurthy, V., Krystek, S. R., Jr., Bush, A., Wei, A., Emanuel, S. L., Das Gupta, R.,
Janjua, A., Cheng, L., Murdock, M., Abramczyk, B., Cohen, D., Lin, Z., Morin, P.,
Davis, J. H., Dabritz, M., McLaughlin, D. C., Russo, K. A., Chao, G., Wright, M. C.,
Jenny, V. A., Engle, L. J., Furfine, E., and Sheriff, S. (2012) Structures of
adnectin/protein complexes reveal an expanded binding footprint, Structure 20, 259-269.

23.

Emanuel, S. L., Engle, L. J., Chao, G., Zhu, R. R., Cao, C., Lin, Z., Yamniuk, A. P.,
Hosbach, J., Brown, J., Fitzpatrick, E., Gokemeijer, J., Morin, P., Morse, B. A., Carvajal,
I. M., Fabrizio, D., Wright, M. C., Das Gupta, R., Gosselin, M., Cataldo, D., Ryseck, R.
P., Doyle, M. L., Wong, T. W., Camphausen, R. T., Cload, S. T., Marsh, H. N., Gottardis,
M. M., and Furfine, E. S. (2011) A fibronectin scaffold approach to bispecific inhibitors
of epidermal growth factor receptor and insulin-like growth factor-I receptor, mAbs 3, 3848.

24.

Carugo, O., and Argos, P. (1997) Protein-protein crystal-packing contacts, Protein
science : a publication of the Protein Society 6, 2261-2263.

25.

Xu, Q., Canutescu, A. A., Wang, G., Shapovalov, M., Obradovic, Z., and Dunbrack, R.
L., Jr. (2008) Statistical analysis of interface similarity in crystals of homologous
proteins, Journal of molecular biology 381, 487-507.

26.

Benjamin, D. C., Berzofsky, J. A., East, I. J., Gurd, F. R., Hannum, C., Leach, S. J.,
Margoliash, E., Michael, J. G., Miller, A., Prager, E. M., and et al. (1984) The antigenic
structure of proteins: a reappraisal, Annual review of immunology 2, 67-101.

27.

Scott, J. K., and Smith, G. P. (1990) Searching for peptide ligands with an epitope
library, Science 249, 386-390.

161

28.

Geysen, H. M., Meloen, R. H., and Barteling, S. J. (1984) Use of peptide synthesis to
probe viral antigens for epitopes to a resolution of a single amino acid, Proceedings of the
National Academy of Sciences of the United States of America 81, 3998-4002.

29.

Jemmerson, R., and Paterson, Y. (1986) Mapping epitopes on a protein antigen by the
proteolysis of antigen-antibody complexes, Science 232, 1001-1004.

30.

Yamada, N., Suzuki, E., and Hirayama, K. (2002) Identification of the interface of a large
protein-protein complex using H/D exchange and Fourier transform ion cyclotron
resonance mass spectrometry, Rapid communications in mass spectrometry : RCM 16,
293-299.

31.

Baerga-Ortiz, A., Hughes, C. A., Mandell, J. G., and Komives, E. A. (2002) Epitope
mapping of a monoclonal antibody against human thrombin by H/D-exchange mass
spectrometry reveals selection of a diverse sequence in a highly conserved protein,
Protein science : a publication of the Protein Society 11, 1300-1308.

32.

Lu, J., Witcher, D. R., White, M. A., Wang, X., Huang, L., Rathnachalam, R., Beals, J.
M., and Kuhstoss, S. (2005) IL-1beta epitope mapping using site-directed mutagenesis
and hydrogen-deuterium exchange mass spectrometry analysis, Biochemistry 44, 1110611114.

33.

Coales, S. J., Tuske, S. J., Tomasso, J. C., and Hamuro, Y. (2009) Epitope mapping by
amide hydrogen/deuterium exchange coupled with immobilization of antibody, on-line
proteolysis, liquid chromatography and mass spectrometry, Rapid communications in
mass spectrometry : RCM 23, 639-647.

34.

Zhang, Q., Willison, L. N., Tripathi, P., Sathe, S. K., Roux, K. H., Emmett, M. R.,
Blakney, G. T., Zhang, H. M., and Marshall, A. G. (2011) Epitope mapping of a 95 kDa
162

antigen in complex with antibody by solution-phase amide backbone hydrogen/deuterium
exchange monitored by Fourier transform ion cyclotron resonance mass spectrometry,
Analytical chemistry 83, 7129-7136.
35.

Pandit, D., Tuske, S. J., Coales, S. J., E, S. Y., Liu, A., Lee, J. E., Morrow, J. A., Nemeth,
J. F., and Hamuro, Y. (2012) Mapping of discontinuous conformational epitopes by
amide hydrogen/deuterium exchange mass spectrometry and computational docking,
Journal of molecular recognition : JMR 25, 114-124.

36.

Jensen, P. F., Jorgensen, T. J., Koefoed, K., Nygaard, F., and Sen, J. W. (2013) Affinity
capture of biotinylated proteins at acidic conditions to facilitate hydrogen/deuterium
exchange mass spectrometry analysis of multimeric protein complexes, Analytical
chemistry 85, 7052-7059.

37.

Takamoto, K., and Chance, M. R. (2006) Radiolytic protein footprinting with mass
spectrometry to probe the structure of macromolecular complexes, Annual review of
biophysics and biomolecular structure 35, 251-276.

38.

Pan, Y., Brown, L., and Konermann, L. (2009) Mapping the structure of an integral
membrane protein under semi-denaturing conditions by laser-induced oxidative labeling
and mass spectrometry, Journal of molecular biology 394, 968-981.

39.

Pan, Y., Stocks, B. B., Brown, L., and Konermann, L. (2009) Structural characterization
of an integral membrane protein in its natural lipid environment by oxidative methionine
labeling and mass spectrometry, Analytical chemistry 81, 28-35.

40.

Jones, L. M., J, B. S., J, A. C., and Gross, M. L. (2011) Fast photochemical oxidation of
proteins for epitope mapping, Analytical chemistry 83, 7657-7661.

163

41.

Iacob, R. E., Chen, G., Ahn, J., Houel, S., Wei, H., Mo, J., Tao, L., Cohen, D., Xie, D.,
Lin, Z., Morin, P. E., Doyle, M. L., Tymiak, A. A., and Engen, J. R. (2014) The influence
of adnectin binding on the extracellular domain of epidermal growth factor receptor,
Journal of the American Society for Mass Spectrometry 25, 2093-2102.

42.

Maleknia, S. D., Brenowitz, M., and Chance, M. R. (1999) Millisecond radiolytic
modification of peptides by synchrotron X-rays identified by mass spectrometry,
Analytical chemistry 71, 3965-3973.

43.

Sharp, J. S., Becker, J. M., and Hettich, R. L. (2004) Analysis of protein solvent
accessible surfaces by photochemical oxidation and mass spectrometry, Analytical
chemistry 76, 672-683.

44.

Aye, T. T., Low, T. Y., and Sze, S. K. (2005) Nanosecond laser-induced photochemical
oxidation method for protein surface mapping with mass spectrometry, Analytical
chemistry 77, 5814-5822.

45.

Hambly, D. M., and Gross, M. L. (2005) Laser flash photolysis of hydrogen peroxide to
oxidize protein solvent-accessible residues on the microsecond timescale, Journal of the
American Society for Mass Spectrometry 16, 2057-2063.

46.

Gau, B. C., Sharp, J. S., Rempel, D. L., and Gross, M. L. (2009) Fast photochemical
oxidation of protein footprints faster than protein unfolding, Analytical chemistry 81,
6563-6571.

47.

Hambly, D., and Gross, M. (2007) Laser flash photochemical oxidation to locate heme
binding and conformational changes in myroglobin, Int J Mass Spectrom 259, 124-129.

48.

Gau, B. C., Chen, H., Zhang, Y., and Gross, M. L. (2010) Sulfate radical anion as a new
reagent for fast photochemical oxidation of proteins, Analytical chemistry 82, 7821-7827.
164

49.

Xu, G., and Chance, M. R. (2004) Radiolytic modification of acidic amino acid residues
in peptides: probes for examining protein-protein interactions, Analytical chemistry 76,
1213-1221.

50.

Xu, G., and Chance, M. R. (2007) Hydroxyl radical-mediated modification of proteins as
probes for structural proteomics, Chemical reviews 107, 3514-3543.

51.

Zhu, W., Smith, J. W., and Huang, C. M. (2010) Mass spectrometry-based label-free
quantitative proteomics, Journal of biomedicine & biotechnology 2010, 840518.

52.

Zhang, H., Gau, B. C., Jones, L. M., Vidavsky, I., and Gross, M. L. (2011) Fast
photochemical oxidation of proteins for comparing structures of protein-ligand
complexes: the calmodulin-peptide model system, Analytical chemistry 83, 311-318.

53.

Edited by Varki, A., Cummings, R. D., Esko, J. D., Freeze, H. H., Stanley, P., Bertozzi,
C. R., Hart, G. W., and Etzler, M. E. (2009) Essentials of Glycobiology (2nd edition),
Cold Spring Harbor Laboratories Press (NY).

165

Yuetian Yan’s Resume
665 S Skinker Blvd., APT 15H
Saint Louis, MO 63105

314-603-7681 (Cell)
karyyan@gmail.com

Education:
Ph.D.: Washington University in St. Louis, United States
Analytical Chemistry (Mass Spectrometry)
Cumulative GPA: 3.92/4.00
BS: Nanjing University, China
Department for Intensive Instruction (major: chemistry)
Cumulative GPA: 90.1 /100

January 2015
May 2008

Industry Experience:
Bristol-Myers Squibb
Biologics Development and Operations/PCO BDAS
Princeton, New Jersey
Research Co-op, Groups of Li Tao and Guodong Chen
July 2014 – December 2014
● Utilized HDX MS to study the local and global conformational impact of non-enzymatic degradation in
the CDRs of a therapeutic antibody, including isomerization and oxidation.
● Utilized HDX MS to study the relationship between structure and the degradation pattern of a
PEGylated Adnectin.
● Utilized native ESI MS and HDX MS to study an intermediate state of an antibody, which is composed
of an extra light chain and a monomer. This study was performed on a Waters Synapt G2 instrument.
Native ESI MS was used to confirm the non-covalent interaction between the light chain and the
monomer. Separation of Fab and Fc followed by Native ESI MS indicated that the extra light chain binds
to the Fab. HDX MS then reported on the interaction site of Fab and the light chain, with support from
structural modeling.
Reliable Biopharmaceutical Corporation
Saint Louis, Missouri
Collaboration service
December 2011 – May 2014
● Provided MS analysis in carbohydrates drug and small molecule drug development, and generated
scientific reports and communicate with customers.
Academic Experience:
Washington University in St. Louis
Saint Louis, Missouri
Research Assistant, Laboratory of Michael L. Gross
June 2010 – Present
● Studied the dimerization of SecA (a 102 kDa protein) by HDX MS. SecA is motor protein in bacteria
preprotein translocation, and both its dimeric interface and active state remain controversial. We
controlled the oligomeric state of SecA by varying salt concentrations, and used HDX MS to characterize
the dimer interface. The determined interface is consistent with Alanine mutation/Analytical
Ultracentrifugation results, and majorly agrees with one of the five controversial crystal structures. A
conformational change from open to closed forms was also identified at the pre-protein binding domain
upon dimerization. This study also provided leads for the active form of SecA.
● Mapped the epitope of Adnectin1-EGFR interaction at the amino-acid residue level by fast
photochemical oxidation of proteins (FPOP) Mass Spectrometry, in collaboration with BMS. The epitope
identified agrees with that from both HDX study and crystallography results, presenting more evidence
of the capability of FPOP in epitope mapping.
166

● Built a tool box with LC/MS and GC/MS for structural characterization of steroid metabolites that are
active pheromones in mice.
● Implemented charge-remote fragmentation using high-energy CID on a MALDI TOF/TOF instrument
to characterize the structures of steroid metabolites.
● Developed a method involving MS to characterized the structure of an unknown steroid metabolite that
activates mouse pheromone-sensing neurons from mouse urine. The proposed structure was confirmed
by customer-synthesis.
● Performed MS/LC-MS analysis of small molecules, polymers, proteins and peptides for internal and
external customers, as a requirement on members of an NIH Research Resource.
Technical Experience:
● Mass spectrometers: Thermo LTQ-Orbitrap/FT; Waters Synapt G2/G2-Si; Brukers Maxis Q-TOF;
and Agilent 7200 Q-TOF GC/MS, etc.)
● LC systems: Waters ACQUITY/ nanoACQUITY systems, Agilent 1100/1200 systems, Eksigent
1D/1D+ systems, and Dionex Ultimate 3000
● Waters HDX system.
● Separation/biochemical techniques: Reverse-phase chromatography; 1D-Electrophoresis; Solid phase
extraction; Buffer exchange; Protein enzyme digestion, etc.
● Bioinformatics tools: Xcalibur, MassLynX, BioPharmaLynx, ProteinLynx Global Server, DynamX,
HDX Workbench, HDX Examiner, MASCOT, ProtMapMS, etc..
Publications:
● Yan Y., Wowor A.J., Auclari S.M., Yu D., Zhang J., May E.R., Gross M.L., Kendall D.A., Cole J.L.,
Analysis of SecA Dimerization in Solution, Biochemistry, 53(19), 3248-3260 (2014)
● Yan Y., Chen G., Wei H., Huang R.Y., Mo J., Rempel D.L., Tymiak A.A., and Gross M.L., Fast
Photochemical Oxidation of Proteins (FPOP) Maps the Epitope of EGFR Binding to Adnectin, JASMS,
25(12), 2084-2092 (2014)
● Yan Y., Rempel, D.L., Holy T.E., Gross M.L., Mass Spectrometry Combinations for Structural
Characterization of Sulfated-Steroid Metabolites, JASMS, 25(5), 869-879 (2014)
● Yan Y., Ubukata M., Cody R.B., Holy T.E., and Gross M.L., High-energy Collision-induceddissociation Causes Charge-remote-fragmentation of Steroid Sulfates on MALDI TOF/TOF, JASMS,
25(8), 1404-1411 (2014)
● Fu X., Yan Y., Xu S.P., Geerlof-vidavsky I., Chong W., Gross M.L. and Holy T.E., A Natural Ligand
for Mouse Vomeronasal Sensory Neurons Revealed by Systematic Correlation Analyses. Reviewed by
Cell.
● Yefremova Y., Al-Majdoub M., Opuni K. F., Koy C., Cui W., Yan Y., Gross M. L., and Glocker M. O.,
“De-novo” amino acid sequence elucidation of protein G′e by combined “Top-Down” and “Bottom-Up”
mass spectrometry, JASMS, DOI: 10.1007/s13361-014-1053-2
Presentations:
● Yan Y., Chen G.., Wei H., Huang R., Mo J., Rempel D.L., Tymiak A.A., Gross M.L., Epitope Mapping
of EGFR Binding to an Adnectin by Fast Photochemical Oxidation of Proteins, ASMS 2014 Annual
Conference
167

● Yan Y., Chen G.., Wei H., Huang R., Mo J., Rempel D.L., Tymiak A.A., Gross M.L., Epitope Mapping
of EGFR Binding to an Adnectin by Fast Photochemical Oxidation of Proteins, 3rd International
Symposium on Higher order structure of Protein Therapeutics (2014). Oral presentation.
● Yan Y., Wowor A.J., Zhang J., Cole J.L., Kendall D.A., Gross M.L., H/DX MS Reveals Features of
SecA Dimeric Interface and a Conformational Change from Open to Closed Forms upon Dimerization,
ASMS 2013 Annual Conference
● Yan Y., Fu X., Holy T.E., Gross M.L., Mass Spectrometric Structural characterization of Sulfated
Steroids: Implications in Animal Communication, ASMS 2012 Annual Conference
● Yan Y., Holy T.E., Gross M.L., Method Development for Structural Characterization of Sulfated
Steroids with Mass Spectrometry: Applications in Animal Communication, ACS 2011 Regional Meeting
Honors and Awards:
● Dean Dissertation Fellowship, Washington University, United States
● Graduate Research Fellowships, Washington University, United States
● Graduate Teaching Fellowships, Washington University, United States
● Endeavour Australia Cheung Kong Scholarship, Melbourne University, Australia
● National People’s Scholarship, 2nd class (top 5%), Nanjing University, China
● National People’s Scholarship, 3rd class (top 10%), Nanjing University, China

2014
2011 – 2013
2009 – 2011
2007
2005, 2007
2006

Professional Reference:
Michael L. Gross, Ph.D.
Professor of Chemistry, Washington University in St. Louis
Department of Chemistry, Campus Box 1134, Washington University in St. Louis
One Brookings Drive, Saint Louis, MO 63130
314-935-4814 (Office)
mgross@wustl.edu
Timothy E. Holy, Ph. D.
Associate Professor of Anatomy and Neurobiology, Washington University School of Medicine
Department of Anatomy & Neurobiology, Campus Box 8108, Washington University in St. Louis
660 S. Euclid Avenue, Saint Louis, MO 63110-1093
314-362-0086 (Office)
holy@wustl.edu
Li Tao, Ph.D.
Sr. Principal Scientist
Global Manufacturing & Supply / Biologics Development & Operations
Bristol-Myers Squibb
Building 9, Room 123
311 Pennington Rockey Hill Rd, Pennington, NJ, 08534
609-818-5527 (Office)
Li.Tao@bms.com

168

